| Code | Display | Comments | 
|---|
 1-8 | Acyclovir [Susceptibility] |  | 
 10-9 | Amdinocillin [Susceptibility] by Serum bactericidal titer |  | 
 100-8 | Cefoperazone [Susceptibility] by Minimum inhibitory concentration (MIC) |  | 
 1000-9 | DBG Ab [Presence] in Serum or Plasma from Blood product unit |  | 
 10000-8 | R wave duration in lead AVR |  |  | 
 100002-5 | Specimen care is maintained |  |  | 
 100003-3 | Team communication is maintained throughout care |  |  | 
 100004-1 | Demonstrates knowledge of the expected psychosocial responses to the procedure |  |  | 
 100005-8 | Demonstrates knowledge of nutritional management related to the procedure |  |  | 
 100006-6 | Demonstrates knowledge of medication management |  |  | 
 100007-4 | Demonstrates knowledge of pain management |  |  | 
 100008-2 | Demonstrates knowledge of wound management |  |  | 
 100009-0 | Demonstrates knowledge of the procedure and expected results |  |  | 
 10001-6 | R wave duration in lead I |  |  | 
 100010-8 | No injury related to procedure equipment, medical supplies, or instrumentation |  |  | 
 100011-6 | No injury related to an electrical source |  |  | 
 100012-4 | Participates in decisions affecting the patient's plan of care |  |  | 
 100013-2 | Participates in the discharge process |  |  | 
 100014-0 | Psychosocial health is maintained at or improved from baseline |  |  | 
 100015-7 | No injury related to positioning due to care or procedure |  |  | 
 100016-5 | No injury related to a laser source |  |  | 
 100017-3 | Perioperative nursing data set outcomes panel [PNDS] |  |  | 
 100018-1 | Hospice care Note |  |  | 
 100019-9 | ALK gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |  | 
 10002-4 | R wave duration in lead II |  |  | 
 100020-7 | GNA11 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |  | 
 100021-5 | GNAQ gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |  | 
 100022-3 | IDH1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |  | 
 100023-1 | IDH2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |  | 
 100024-9 | SETBP1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |  | 
 100025-6 | SRSF2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |  | 
 100026-4 | MET gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |  | 
 100027-2 | SMAD4 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |  | 
 100028-0 | FBXW7 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |  | 
 100029-8 | Cancer related multigene analysis in Plasma cell-free DNA by Molecular genetics method |  | 
 10003-2 | R wave duration in lead III |  |  | 
 100030-6 | Axis I: Temporal aspects score [Mainz Pain Staging System] |  |  | 
 100031-4 | Axis II: Spatial aspects score [Mainz Pain Staging System] |  |  | 
 100032-2 | Axis III: Drug taking behavior score [Mainz Pain Staging System] |  |  | 
 100033-0 | Axis IV: Utilization of the health care system score [Mainz Pain Staging System] |  |  | 
 100034-8 | Provider of automated external defibrillator use |  |  | 
 100035-5 | Exam finding location of Chest |  |  | 
 100036-3 | Exam finding location of Lung |  |  | 
 100037-1 | Patient contact disposition EMS unit |  |  | 
 100038-9 | Patient evaluation disposition EMS unit |  |  | 
 100039-7 | Crew disposition for patient care EMS unit |  |  | 
 10004-0 | R wave duration in lead V1 |  |  | 
 100040-5 | Patient transport disposition EMS unit |  |  | 
 100041-3 | Aminoglycoside [Susceptibility] |  | 
 100042-1 | Atovaquone [Susceptibility] |  | 
 100043-9 | Azithromycin+Ethambutol [Susceptibility] |  | 
 100044-7 | Cefcapene [Susceptibility] |  | 
 100045-4 | Cefozopran [Susceptibility] |  | 
 100046-2 | Cefquinome [Susceptibility] |  | 
 100047-0 | Cefteram [Susceptibility] |  | 
 100048-8 | Clarithromycin+Ethambutol [Susceptibility] |  | 
 100049-6 | Eravacycline [Susceptibility] |  | 
 10005-7 | R wave duration in lead V2 |  |  | 
 100050-4 | Erythromycin+Ethambutol [Susceptibility] |  | 
 100051-2 | Ethambutol+rifAMPin [Susceptibility] |  | 
 100052-0 | Flomoxef [Susceptibility] |  | 
 100053-8 | Fluoroquinolone [Susceptibility] |  | 
 100054-6 | Gamithromycin [Susceptibility] |  | 
 100055-3 | Optochin [Susceptibility] |  | 
 100056-1 | Panipenem [Susceptibility] |  | 
 100057-9 | Prothionamide [Susceptibility] |  | 
 100058-7 | Prulifloxacin [Susceptibility] |  | 
 100059-5 | Rifapentine [Susceptibility] |  | 
 10006-5 | R wave duration in lead V3 |  |  | 
 100060-3 | Tildipirosin [Susceptibility] |  | 
 100061-1 | Tosufloxacin [Susceptibility] |  | 
 100062-9 | Standard Dermatology Outcome Measures panel |  |  | 
 100063-7 | Primary skin concern |  |  | 
 100064-5 | Itch severity Reporting Period - Reported |  |  | 
 100065-2 | Satisfied with treatment |  |  | 
 100066-0 | Specular microscopy panel |  |  | 
 100067-8 | Eye Image magnification |  |  | 
 100068-6 | Right eye Fixation point [Angle] |  |  | 
 100069-4 | Left eye Fixation point [Angle] |  |  | 
 10007-3 | R wave duration in lead V4 |  |  | 
 100070-2 | Right cornea Cell density |  |  | 
 100071-0 | Left cornea Cell density |  |  | 
 100072-8 | Right cornea Coefficient of variation |  |  | 
 100073-6 | Left cornea Coefficient of variation |  |  | 
 100074-4 | Right cornea Hexagonality |  |  | 
 100075-1 | Left cornea Hexagonality |  |  | 
 100076-9 | Right cornea Endothelial cells counted |  |  | 
 100077-7 | Left cornea Endothelial cells counted |  |  | 
 100078-5 | Right cornea Endothelial cell area.min |  |  | 
 100079-3 | Left cornea Endothelial cell area.min |  |  | 
 10008-1 | R wave duration in lead V5 |  |  | 
 100080-1 | Right cornea Endothelial cell area.max |  |  | 
 100081-9 | Left cornea Endothelial cell area.max |  |  | 
 100082-7 | Right cornea Endothelial cell area.mean |  |  | 
 100083-5 | Left cornea Endothelial cell area.mean |  |  | 
 100084-3 | Right cornea Cell area.standard deviation |  |  | 
 100085-0 | Left cornea Cell area.standard deviation |  |  | 
 100086-8 | Right cornea Type of Analysis method by Specular microscopy |  |  | 
 100087-6 | Toxocara canis 24-35kD IgG Ab [Presence] in Serum by Immunoblot |  | 
 100088-4 | Taenia solium larva Ab bands panel - Serum by Immunoblot |  | 
 100089-2 | Taenia solium larva 6-8kD Ab [Presence] in Serum by Immunoblot |  | 
 10009-9 | R wave duration in lead V6 |  |  | 
 100090-0 | Taenia solium larva 45kD Ab [Presence] in Serum by Immunoblot |  | 
 100091-8 | Trypanosoma cruzi Ab [Units/volume] in Serum by Immunoassay |  | 
 100092-6 | Trypanosoma cruzi Ab bands panel - Serum by Immunoblot |  | 
 100093-4 | Trypanosoma cruzi 15-16kD IgG Ab [Presence] in Serum by Immunoblot |  | 
 100094-2 | Trypanosoma cruzi 21-22kD IgG Ab [Presence] in Serum by Immunoblot |  | 
 100095-9 | Trypanosoma cruzi 27-28kD IgG Ab [Presence] in Serum by Immunoblot |  | 
 100096-7 | Trypanosoma cruzi 42kD IgG Ab [Presence] in Serum by Immunoblot |  | 
 100097-5 | Trypanosoma cruzi 45-47kD IgG Ab [Presence] in Serum by Immunoblot |  | 
 100098-3 | Trypanosoma cruzi 120-200kD IgG Ab [Presence] in Serum by Immunoblot |  | 
 100099-1 | Trypanosoma cruzi 160kD IgG Ab [Presence] in Serum by Immunoblot |  | 
 1001-7 | DBG Ab [Presence] in Serum or Plasma from Donor |  | 
 10010-7 | R' wave amplitude in lead AVF |  |  | 
 100100-7 | Fasciola sp IgG Ab [Presence] in Serum by Immunoassay |  | 
 100101-5 | Fasciola sp 8-9kD IgG Ab [Presence] in Serum by Immunoblot |  | 
 100102-3 | Fasciola sp 27-28kD IgG Ab [Presence] in Serum by Immunoblot |  | 
 100103-1 | Fasciola sp 60kD IgG Ab [Presence] in Serum by Immunoblot |  | 
 100104-9 | Fasciola sp 42kD IgG Ab [Presence] in Serum by Immunoblot |  | 
 100105-6 | Filaria IgG and IgM panel - Serum |  | 
 100106-4 | Filaria IgG Ab [Presence] in Serum by Immunoassay |  | 
 100107-2 | Leishmania sp IgG Ab [Presence] in Serum by Immunoassay |  | 
 100108-0 | Leishmania sp IgG Ab [Units/volume] in Serum by Immunoassay |  | 
 100109-8 | Leishmania sp Ab bands panel - Serum by Immunoblot |  | 
 10011-5 | R' wave amplitude in lead AVL |  |  | 
 100110-6 | Leishmania sp 14kD IgG Ab [Presence] in Serum by Immunoblot |  | 
 100111-4 | Leishmania sp 16kD IgG Ab [Presence] in Serum by Immunoblot |  | 
 100112-2 | Fasciola sp Ab bands panel - Serum by Immunoblot |  | 
 100113-0 | Helicobacter pylori Ab panel - Serum |  | 
 100114-8 | Toxoplasma gondii 30kD Ab [Presence] in Serum by Immunoblot |  | 
 100115-5 | Toxoplasma gondii 31kD Ab [Presence] in Serum by Immunoblot |  | 
 100116-3 | Toxoplasma gondii 33kD Ab [Presence] in Serum by Immunoblot |  | 
 100117-1 | Toxoplasma gondii 40kD Ab [Presence] in Serum by Immunoblot |  | 
 100118-9 | Toxoplasma gondii 41kD Ab [Presence] in Serum by Immunoblot |  | 
 100119-7 | Toxoplasma gondii 45kD Ab [Presence] in Serum by Immunoblot |  | 
 10012-3 | R' wave amplitude in lead AVR |  |  | 
 100120-5 | Chlamydia trachomatis Ab panel - Serum |  | 
 100121-3 | Chlamydia trachomatis IgA Ab [Presence] in Serum by Immunoassay |  | 
 100122-1 | Chlamydophila pneumoniae Ab panel - Serum |  | 
 100123-9 | Chlamydophila pneumoniae IgA Ab [Presence] in Serum by Immunoassay |  | 
 100124-7 | Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum by Immunoassay |  | 
 100125-4 | Chlamydophila psittaci Ab panel - Serum |  | 
 100126-2 | Bordetella pertussis Ab.IgG panel - Serum |  | 
 100127-0 | Campylobacter sp Ab panel - Serum |  | 
 100128-8 | Cryptococcus sp Ag panel - Serum |  | 
 100129-6 | Schistosoma sp Ab [Titer] in Serum by Hemagglutination |  | 
 10013-1 | R' wave amplitude in lead I |  |  | 
 100130-4 | Schistosoma mansoni Ab [Presence] in Serum by Immunoblot |  | 
 100131-2 | Schistosoma sp 8kD Ab [Presence] in Serum by Immunoblot |  | 
 100132-0 | Schistosoma sp 9kD Ab [Presence] in Serum by Immunoblot |  | 
 100133-8 | Schistosoma sp 10kD Ab [Presence] in Serum by Immunoblot |  | 
 100134-6 | Schistosoma sp 11kD Ab [Presence] in Serum by Immunoblot |  | 
 100135-3 | Schistosoma sp 12-13kD Ab [Presence] in Serum by Immunoblot |  | 
 100136-1 | Schistosoma sp 14-15kD Ab [Presence] in Serum by Immunoblot |  | 
 100137-9 | Schistosoma sp 15-16kD Ab [Presence] in Serum by Immunoblot |  | 
 100138-7 | Schistosoma sp 18-19kD Ab [Presence] in Serum by Immunoblot |  | 
 100139-5 | Schistosoma sp 22-24kD Ab [Presence] in Serum by Immunoblot |  | 
 10014-9 | R' wave amplitude in lead II |  |  | 
 100140-3 | Schistosoma sp 30-34kD Ab [Presence] in Serum by Immunoblot |  | 
 100141-1 | Schistosoma sp 65kD Ab [Presence] in Serum by Immunoblot |  | 
 100142-9 | Schistosoma sp 70kD Ab [Presence] in Serum by Immunoblot |  | 
 100143-7 | Schistosoma sp 80kD Ab [Presence] in Serum by Immunoblot |  | 
 100144-5 | Schistosoma sp 95kD Ab [Presence] in Serum by Immunoblot |  | 
 100145-2 | Schistosoma sp 110kD Ab [Presence] in Serum by Immunoblot |  | 
 100146-0 | Schistosoma sp 120kD Ab [Presence] in Serum by Immunoblot |  | 
 100147-8 | Toxoplasma gondii Ab bands panel - Serum by Immunoblot |  | 
 100148-6 | Schistosoma sp Ab bands panel - Serum by Immunoblot |  | 
 100149-4 | 6-oxo-piperidine-2-carboxylate and 6(R+S)-oxo-propylpiperidine-2-carboxylate panel - Urine and Serum or Plasma |  | 
 10015-6 | R' wave amplitude in lead III |  |  | 
 100150-2 | 6(R+S)-oxo-propylpiperidine-2-carboxylate [Moles/volume] in Plasma |  | 
 100151-0 | 6-oxo-piperidine-2-carboxylate [Moles/volume] in Plasma |  | 
 100152-8 | 6-oxo-piperidine-2-carboxylate/Creatinine [Molar ratio] in Urine |  | 
 100153-6 | 6(R+S)-oxo-propylpiperidine-2-carboxylate/Creatinine [Molar ratio] in Urine |  | 
 100154-4 | Specimen collection supervision level |  | 
 100155-1 | Left cornea Type of Analysis method by Specular microscopy |  |  | 
 100156-9 | SARS-CoV-2 (COVID-19) variant [Type] in Specimen by NAA with probe detection |  | 
 100157-7 | SARS-CoV-2 (COVID-19) lineage [Type] in Specimen by Sequencing |  | 
 100158-5 | Microalbumin [Mass/volume] in Urine collected for unspecified duration |  | 
 100159-3 | Knee Society Score pre-op panel [Knee Society Score] |  |  | 
 10016-4 | R' wave amplitude in lead V1 |  |  | 
 100160-1 | Knee replacement |  |  | 
 100161-9 | Charnley Functional Classification |  |  | 
 100162-7 | Knee alignment W standing X-ray measured |  |  | 
 100163-5 | Knee medial AndOr lateral instability W full extension |  |  | 
 100164-3 | Knee AP instability W 90 degree flexion |  |  | 
 100165-0 | Knee range of motion |  |  | 
 100166-8 | Flexion contracture range of Knee |  |  | 
 100167-6 | Extensor lag range of Knee |  |  | 
 100168-4 | Knee pain severity with level walking |  |  | 
 100169-2 | Knee pain severity with stairs or inclines |  |  | 
 10017-2 | R' wave amplitude in lead V2 |  |  | 
 100170-0 | Knee feels normal |  |  | 
 100171-8 | Satisfaction with level of knee pain while sitting |  |  | 
 100172-6 | Satisfaction with level of knee pain while lying in bed |  |  | 
 100173-4 | Satisfaction with knee function while getting out of bed |  |  | 
 100174-2 | Satisfaction with knee function while performing light household duties |  |  | 
 100175-9 | Satisfaction with knee function while performing recreational activities |  |  | 
 100176-7 | Expect surgery to relieve pain |  |  | 
 100177-5 | Expect surgery will improve ability to perform activities of daily living |  |  | 
 100178-3 | Expect surgery will improve ability to perform leisure, recreational, or sports activities |  |  | 
 100179-1 | Walk without assistive mobility devices |  |  | 
 10018-0 | R' wave amplitude in lead V3 |  |  | 
 100180-9 | Assistive mobility devices used |  |  | 
 100181-7 | Assistive mobility devices used due to health condition |  |  | 
 100182-5 | Duration of standing before sitting due to knee discomfort |  |  | 
 100183-3 | Duration of walking before stopping due to knee discomfort |  |  | 
 100184-1 | How bothersome is knee when walking on an uneven surface |  |  | 
 100185-8 | How bothersome is knee when turning or pivoting leg |  |  | 
 100186-6 | How bothersome is knee when climbing up or down a flight of stairs |  |  | 
 100187-4 | How bothersome is knee when getting up from a low seat without armrests |  |  | 
 100188-2 | How bothersome is knee when getting into or out of a car |  |  | 
 100189-0 | How bothersome is knee when moving laterally |  |  | 
 10019-8 | R' wave amplitude in lead V4 |  |  | 
 100190-8 | How bothersome is knee when climbing a ladder or step stool |  |  | 
 100191-6 | How bothersome is knee when carrying a bag for one block |  |  | 
 100192-4 | How bothersome is knee when squatting |  |  | 
 100193-2 | How bothersome is knee when kneeling |  |  | 
 100194-0 | How bothersome is knee when running |  |  | 
 100195-7 | Pain severity--during activity |  |  | 
 100196-5 | Pre-op total score [Knee Society Score] |  |  | 
 100197-3 | Exercise activity and pain severity panel |  |  | 
 100198-1 | Pre-op objective knee indicators score [Knee Society Score] |  |  | 
 100199-9 | Pre-op symptoms score [Knee Society Score] |  |  | 
 1002-5 | DBG Ab [Presence] in Serum or Plasma |  | 
 10020-6 | R' wave amplitude in lead V5 |  |  | 
 100200-5 | Pre-op patient expectations score [Knee Society Score] |  |  | 
 100201-3 | Pre-op functional activities score [Knee Society Score] |  |  | 
 100202-1 | Pre-op discretionary knee activities score [Knee Society Score] |  |  | 
 100203-9 | Knee Society Score post-op panel [Knee Society Score] |  |  | 
 100204-7 | Accuracy of pre-surgery expectations of pain relief |  |  | 
 100205-4 | Accuracy of pre-surgery expectations to perform activities of daily living |  |  | 
 100206-2 | Accuracy of pre-surgery expectations to perform leisure, recreational, or sports activities |  |  | 
 100207-0 | Post-op total score [Knee Society Score] |  |  | 
 100208-8 | Post-op objective knee indicators score [Knee Society Score] |  |  | 
 100209-6 | Post-op symptoms score [Knee Society Score] |  |  | 
 10021-4 | R' wave amplitude in lead V6 |  |  | 
 100210-4 | Post-op patient expectations score [Knee Society Score] |  |  | 
 100211-2 | Post-op functional activities score [Knee Society Score] |  |  | 
 100212-0 | Post-op discretionary knee activities score [Knee Society Score] |  |  | 
 100213-8 | Prostate cancer multigene analysis in Blood or Tissue by Molecular genetics method |  | 
 100214-6 | Dental model prior authorization Document |  |  | 
 100215-3 | Episode of care medical records Document Transplant surgery |  |  | 
 100216-1 | Surgical synoptic report |  |  | 
 100217-9 | Surgical oncology synoptic report |  |  | 
 100218-7 | Surgical oncology of colon synoptic report |  |  | 
 100219-5 | Surgical oncology of melanoma synoptic report |  |  | 
 10022-2 | R' wave duration in lead AVF |  |  | 
 100220-3 | Surgical oncology of breast synoptic report |  |  | 
 100221-1 | Surgical oncology of thyroid synoptic report |  |  | 
 100222-9 | Surgical oncology of pancreas synoptic report |  |  | 
 100223-7 | Physical findings of Retina Narrative |  |  | 
 100224-5 | Cardiac left ventricular segmental wall motion by echo panel |  |  | 
 100225-2 | Bone density quantitative ultrasound study |  |  | 
 100226-0 | Small bowel capsule endoscopy study Document |  |  | 
 100227-8 | Colon capsule endoscopy study Document |  |  | 
 100228-6 | Upper gastrointestinal capsule endoscopy study Document |  |  | 
 100229-4 | Endoscopic ultrasound study Document |  |  | 
 10023-0 | R' wave duration in lead AVL |  |  | 
 100230-2 | Routine prenatal assessment panel |  |  | 
 100231-0 | Endobronchial ultrasound study |  |  | 
 100232-8 | Impacts of Events Scale-Revised panel |  |  | 
 100233-6 | Reminders brought back feelings about adverse event |  |  | 
 100234-4 | Trouble staying asleep |  |  | 
 100235-1 | Other things triggered persistent thoughts about adverse event |  |  | 
 100236-9 | Felt irritable AndOr angry |  |  | 
 100237-7 | Avoided getting upset when unintentionally thought about adverse event |  |  | 
 100238-5 | Thought about adverse event unintentionally |  |  | 
 100239-3 | Felt as if adverse event did not happen |  |  | 
 10024-8 | R' wave duration in lead AVR |  |  | 
 100240-1 | Avoided reminders of adverse event |  |  | 
 100241-9 | Experienced mental images of adverse event |  |  | 
 100242-7 | Easily startled |  |  | 
 100243-5 | Tried to not think of adverse event |  |  | 
 100244-3 | Aware of feelings about adverse event, but did not address them |  |  | 
 100245-0 | Feelings about adverse event were numb |  |  | 
 100246-8 | Acted or felt the same as during adverse event |  |  | 
 100247-6 | Trouble falling asleep |  |  | 
 100248-4 | Waves of strong feelings about adverse event |  |  | 
 100249-2 | Tried to remove adverse event from memory |  |  | 
 10025-5 | R' wave duration in lead I |  |  | 
 100250-0 | Trouble concentrating |  |  | 
 100251-8 | Reminders of adverse event caused physical reactions |  |  | 
 100252-6 | Had dreams about adverse event |  |  | 
 100253-4 | Felt watchful and on-guard |  |  | 
 100254-2 | Tried not to talk about adverse event |  |  | 
 100255-9 | Total score [Impact of Event Scale-Revised] |  |  | 
 100256-7 | Fallen in last 6 months |  |  | 
 100257-5 | Feel unsteady when standing or walking |  |  | 
 100258-3 | History of fall related injury |  |  | 
 100259-1 | Aware of tactile sensations |  |  | 
 10026-3 | R' wave duration in lead II |  |  | 
 100260-9 | Easy to describe thoughts AndOr feelings |  |  | 
 100261-7 | Critical of own thoughts AndOr feelings |  |  | 
 100262-5 | Able to notice distressing thoughts AndOr feelings without having to react |  |  | 
 100263-3 | Easily distracted |  |  | 
 100264-1 | Able to notice thoughts AndOr feelings without being overwhelmed |  |  | 
 100265-8 | Aware of dietary intake impact on self |  |  | 
 100266-6 | Difficult to describe thoughts AndOr feelings |  |  | 
 100267-4 | Aware of auditory stimuli |  |  | 
 100268-2 | Able to avoid immediate reaction in difficult situations |  |  | 
 100269-0 | Do things without paying attention |  |  | 
 10027-1 | R' wave duration in lead III |  |  | 
 100270-8 | Recover quickly from distressing thoughts AndOr images |  |  | 
 100271-6 | Aware of olfactory stimuli |  |  | 
 100272-4 | Aware of visual stimuli |  |  | 
 100273-2 | Aware of emotions affect on thoughts AndOr behavior |  |  | 
 100274-0 | Observing score [FFMQ] |  |  | 
 100275-7 | Describing score [FFMQ] |  |  | 
 100276-5 | Acting with awareness score [FFMQ] |  |  | 
 100277-3 | Nonjudging score [FFMQ] |  |  | 
 100278-1 | Nonreactivity score [FFMQ] |  |  | 
 100279-9 | Total score [FFMQ] |  |  | 
 10028-9 | R' wave duration in lead V1 |  |  | 
 100280-7 | Five Facet Mindfulness Questionnaire panel [FFMQ] |  |  | 
 100281-5 | D Ab [Units/volume] in Serum or Plasma |  | 
 100282-3 | Vaccine exemption certificate |  |  | 
 100283-1 | Harris Hip Score panel [Harris Hip Score] |  |  | 
 100284-9 | Walking - functional ability |  |  | 
 100285-6 | Comfortable seated position |  |  | 
 100286-4 | Able to board public transportation |  |  | 
 100287-2 | Put on shoes and socks |  |  | 
 100288-0 | Absence of deformity score [Harris Hip Score] |  |  | 
 100289-8 | Absence of hip deformity measurements |  |  | 
 10029-7 | R' wave duration in lead V2 |  |  | 
 100290-6 | Range of motion score [Harris Hip Score] |  |  | 
 100291-4 | Total score [Harris Hip Score] |  |  | 
 100292-2 | Pre-op patient satisfaction score [Knee Society Score] |  |  | 
 100293-0 | Hip Flexion range of motion |  |  | 
 100294-8 | Hip Abduction range of motion |  |  | 
 100295-5 | Hip Adduction range of motion |  |  | 
 100296-3 | Hip External rotation range of motion |  |  | 
 100297-1 | Hip Internal rotation range of motion |  |  | 
 100298-9 | Repetition count |  |  | 
 100299-7 | Post-op patient satisfaction score [Knee Society Score] |  |  | 
 1003-3 | Indirect antiglobulin test.complement specific reagent [Presence] in Serum or Plasma |  | 
 10030-5 | R' wave duration in lead V3 |  |  | 
 100300-3 | End time Unspecified body region |  |  | 
 100301-1 | Start time Unspecified body region |  |  | 
 100302-9 | Time period start and end panel Unspecified body region |  |  | 
 100303-7 | Condition certainty of presence |  |  | 
 100304-5 | Flights climbed [#] Reporting Period |  |  | 
 100305-2 | IDH1 gene exon 4 targeted mutation analysis [Presence] in Blood or Marrow by Molecular genetics method |  | 
 100306-0 | IDH2 gene exon 4 targeted mutation analysis [Presence] in Blood or Marrow by Molecular genetics method |  | 
 100307-8 | Behavioral screening elder mistreatment |  |  | 
 100308-6 | Need help getting to essential places |  |  | 
 100309-4 | Activity support person |  |  | 
 10031-3 | R' wave duration in lead V4 |  |  | 
 100310-2 | Reliability of support person |  |  | 
 100311-0 | Need help to make sure there is enough food, medicines or any other things needed in house |  |  | 
 100312-8 | Person or persons that makes sure there is enough food, medicines or any other things needed in house |  |  | 
 100313-6 | Need help with household things such as cook meals, help feed, or provide correct medicines each day |  |  | 
 100314-4 | Need help with house cleaning or yard work |  |  | 
 100315-1 | Need help getting out of bed, showered, or dressed |  |  | 
 100316-9 | Need help to make sure bills get paid |  |  | 
 100317-7 | Relationship of usual support person for daily activities |  |  | 
 100318-5 | Have help with finances AndOr financial decisions |  |  | 
 100319-3 | Relationship of financial support person |  |  | 
 10032-1 | R' wave duration in lead V5 |  |  | 
 100320-1 | Financial support person usually asks for permission before making decisions |  |  | 
 100321-9 | Financial support person usually makes good decisions about finances |  |  | 
 100322-7 | Have access to paperwork for financial decisions made |  |  | 
 100323-5 | Financial support person forged signature |  |  | 
 100324-3 | Coercion of financial support person for signing a document in order to get money or possessions |  |  | 
 100325-0 | Experienced theft by support person |  |  | 
 100326-8 | Money spent or property sold without permission |  |  | 
 100327-6 | Stranger forged signature for financial gain |  |  | 
 100328-4 | Stranger forced document signature for financial gain |  |  | 
 100329-2 | Feared for safety due to verbal attack |  |  | 
 10033-9 | R' wave duration in lead V6 |  |  | 
 100330-0 | Felt humiliated due to ridicule |  |  | 
 100331-8 | Coerced to do something |  |  | 
 100332-6 | Ignored by close friend or relative for extended period |  |  | 
 100333-4 | Physically hit or threatened |  |  | 
 100334-2 | Been physically hurt with some degree of injury |  |  | 
 100335-9 | Coerced sexual activity |  |  | 
 100336-7 | Coerced touching of private body parts of self or others |  |  | 
 100337-5 | Coerced to undress or expose private body area |  |  | 
 100338-3 | Photographed in any degree of nudity without consent |  |  | 
 100339-1 | Experienced attempted physical restraint |  |  | 
 10034-7 | S wave amplitude in lead AVF |  |  | 
 100340-9 | Range of motion panel Hip |  |  | 
 100341-7 | Rubella virus IgG Ab index [Units/volume] in Serum and CSF |  | 
 100342-5 | Volatile Organic Compounds associated with SARS-CoV-2 infection [Presence] in Exhaled gas by Gas chromatography-mass spectrometry |  | 
 100343-3 | Influenza virus B RNA [Presence] in Saliva (oral fluid) by NAA with probe detection |  | 
 100344-1 | Influenza virus A RNA [Presence] in Saliva (oral fluid) by NAA with probe detection |  | 
 100345-8 | Influenza virus A and B and SARS-CoV-2 (COVID-19) RNA panel - Specimen by NAA with probe detection |  | 
 100346-6 | Clotting time.extrinsic coagulation system activated.platelets inhibited of Blood by Rotational TEG |  | 
 100347-4 | Clot formation.extrinsic coagulation system activated.platelets inhibited [Time] in Blood by Rotational TEG |  | 
 100348-2 | Model for end-stage liver disease sodium score |  |  | 
 100349-0 | US.doppler Penis vessels W vasodilator IV |  |  | 
 10035-4 | S wave amplitude in lead AVL |  |  | 
 100350-8 | Sesamum indicum 1 IgE Ab [Units/volume] in Serum |  | 
 100351-6 | Pioglitazone [Presence] in Serum or Plasma |  | 
 100352-4 | Rosiglitazone [Presence] in Serum or Plasma |  | 
 100353-2 | Norwalk Community Health Center Screening Tool [NCHC] |  |  | 
 100354-0 | Frequency of participating in multi-modal communication without assistance |  |  | 
 100355-7 | Frequency of participating in spoken language expression communication without assistance |  |  | 
 100356-5 | Chlamydia trachomatis and Neisseria gonorrhoeae and Trichomonas vaginalis DNA [Identifier] in Specimen by NAA with probe detection |  | 
 100357-3 | Naloxone [Presence] in Cord tissue by Screen method |  | 
 100358-1 | Phentermine [Presence] in Cord tissue by Screen method |  | 
 100359-9 | Gliadin 33 mer peptide [Mass/volume] in Stool by Immunoassay |  | 
 10036-2 | S wave amplitude in lead AVR |  |  | 
 100360-7 | Brief Resilience Scale panel [BRS] |  |  | 
 100361-5 | Quickly recover from bad events |  |  | 
 100362-3 | Difficulty making it through stressful events |  |  | 
 100363-1 | Easily recover from a stressful event |  |  | 
 100364-9 | Difficulty recovering from bad events |  |  | 
 100365-6 | Easily recover from difficulties |  |  | 
 100366-4 | Lengthy recovery from setbacks |  |  | 
 100367-2 | Total Score BRS |  |  | 
 100368-0 | Amino Acids Urea Cycle Panel - Serum or Plasma by LC/MS/MS |  | 
 100369-8 | NM Thyroid gland Views W Tl-201 IV |  |  | 
 10037-0 | S wave amplitude in lead I |  |  | 
 100370-6 | Orthopoxvirus DNA [Identifier] in Specimen by NAA with probe detection |  | 
 100371-4 | Titin Ab [Units/volume] in Serum by Immunoassay |  | 
 100372-2 | Abiraterone [Mass/volume] in Serum or Plasma |  | 
 100373-0 | Eucheuma IgG Ab [Units/volume] in Serum |  | 
 100374-8 | Aloe vera IgG Ab [Units/volume] in Serum |  | 
 100375-5 | Anise IgG Ab [Units/volume] in Serum |  | 
 100376-3 | Bambusa vulgaris IgG Ab [Units/volume] in Serum |  | 
 100377-1 | Goat cheese IgG Ab [Units/volume] in Serum |  | 
 100378-9 | Sheep cheese IgG Ab [Units/volume] in Serum |  | 
 100379-7 | Leeks IgG Ab [Units/volume] in Serum |  | 
 10038-8 | S wave amplitude in lead II |  |  | 
 100380-5 | Red cabbage IgG Ab [Units/volume] in Serum |  | 
 100381-3 | Mentha balsamea Wild IgG Ab [Units/volume] in Serum |  | 
 100382-1 | FDA package insert REMS addressed risk |  |  | 
 100383-9 | Monkeypox virus DNA [Presence] in Specimen by NAA with probe detection |  | 
 100384-7 | Rapeseed IgG Ab [Units/volume] in Serum |  | 
 100385-4 | Corn salad IgG Ab [Units/volume] in Serum |  | 
 100386-2 | Rosemary IgG Ab [Units/volume] in Serum |  | 
 100387-0 | Poppy Seed IgG Ab [Units/volume] in Serum |  | 
 100388-8 | Cocoa IgG Ab [Units/volume] in Serum |  | 
 100389-6 | Pistachio IgG Ab [Units/volume] in Serum |  | 
 10039-6 | S wave amplitude in lead III |  |  | 
 100390-4 | Sunflower Seed IgG Ab [Units/volume] in Serum |  | 
 100391-2 | Dates IgG Ab [Units/volume] in Serum |  | 
 100392-0 | Duck meat IgG Ab [Units/volume] in Serum |  | 
 100393-8 | Allergen Mushroom mix 2 (Xerocomus, Boletus) IgG Ab [Units/volume] in Serum |  | 
 100394-6 | Astacoidea IgG Ab [Units/volume] in Serum |  | 
 100395-3 | Carob IgG Ab [Units/volume] in Serum |  | 
 100396-1 | Brassica napus IgG Ab [Units/volume] in Serum |  | 
 100397-9 | Goat Meat IgG Ab [Units/volume] in Serum |  | 
 100398-7 | Goose meat IgG Ab [Units/volume] in Serum |  | 
 100399-5 | Ostrich meat IgG Ab [Units/volume] in Serum |  | 
 1004-1 | Direct antiglobulin test.complement specific reagent [Presence] on Red Blood Cells |  | 
 10040-4 | S wave amplitude in lead V1 |  |  | 
 100400-1 | Quail meat IgG Ab [Units/volume] in Serum |  | 
 100401-9 | Rabbit meat IgG Ab [Units/volume] in Serum |  | 
 100402-7 | Venison meat IgG Ab [Units/volume] in Serum |  | 
 100403-5 | Guineafowl IgG Ab [Units/volume] in Serum |  | 
 100404-3 | Horse meat IgG Ab [Units/volume] in Serum |  | 
 100405-0 | Kefir IgG Ab [Units/volume] in Serum |  | 
 100406-8 | Butter IgG Ab [Units/volume] in Serum |  | 
 100407-6 | Camembert cheese IgG Ab [Units/volume] in Serum |  | 
 100408-4 | Emmental cheese IgG Ab [Units/volume] in Serum |  | 
 100409-2 | Processed cheese IgG Ab [Units/volume] in Serum |  | 
 10041-2 | S wave amplitude in lead V2 |  |  | 
 100410-0 | Curd cheese IgG Ab [Units/volume] in Serum |  | 
 100411-8 | Sugar Beet IgG Ab [Units/volume] in Serum |  | 
 100412-6 | Chinese cabbage IgG Ab [Units/volume] in Serum |  | 
 100413-4 | Fennel Fresh IgG Ab [Units/volume] in Serum |  | 
 100414-2 | Gourd IgG Ab [Units/volume] in Serum |  | 
 100415-9 | Kale IgG Ab [Units/volume] in Serum |  | 
 100416-7 | Savoy cabbage IgG Ab [Units/volume] in Serum |  | 
 100417-5 | Vitis sp leaf IgG Ab [Units/volume] in Serum |  | 
 100418-3 | Liquorice IgG Ab [Units/volume] in Serum |  | 
 100419-1 | Snow pea IgG Ab [Units/volume] in Serum |  | 
 10042-0 | S wave amplitude in lead V3 |  |  | 
 100420-9 | Fava bean IgG Ab [Units/volume] in Serum |  | 
 100421-7 | Chick Pea IgG Ab [Units/volume] in Serum |  | 
 100422-5 | Chicory IgG Ab [Units/volume] in Serum |  | 
 100423-3 | Allergy Mushroom Mix 1 (Button + oyster + Shiitaki + chanterelle mushroom) IgG Ab [Units/volume] in Serum |  | 
 100424-1 | 8(9)-Cholestenol [Mass/volume] in Serum or Plasma |  | 
 100425-8 | DiHydro T-Mas [Mass/volume] in Serum or Plasma |  | 
 100426-6 | Squalene [Mass/volume] in Serum or Plasma |  | 
 100427-4 | Stigmasterol [Mass/volume] in Serum or Plasma |  | 
 100428-2 | Carnitine free and total and acylcarnitine panel - Urine |  | 
 100429-0 | LRBA deficiency panel - Blood |  | 
 10043-8 | S wave amplitude in lead V4 |  |  | 
 100430-8 | Cells.LRBA+/100 Cells.CD3+CD14-CD45+ in Blood by Flow cytometry (FC) |  | 
 100431-6 | Cells.CD3+CD14-CD45+.LRBA mean fluorescence intensity in Blood by Flow cytometry (FC) |  | 
 100432-4 | Cells.LRBA+/100 Cells.CD3-CD14-CD19+CD45+ in Blood by Flow cytometry (FC) |  | 
 100433-2 | Cells.CD3-CD14-CD19+CD45+.LRBA mean fluorescence intensity in Blood by Flow cytometry (FC) |  | 
 100434-0 | Orthopoxvirus.non-variola DNA [Presence] in Specimen by NAA with probe detection |  | 
 100435-7 | Glial fibrillary acidic protein [Mass/volume] in Serum by Immunoassay |  | 
 100436-5 | Ubiquitin carboxyl-terminal hydrolase-L1 [Mass/volume] in Serum by Immunoassay |  | 
 100437-3 | Norsufentanil [Mass/volume] in Urine by Confirmatory method |  | 
 100438-1 | Adolescent medicine Outpatient Progress note |  |  | 
 100439-9 | Allergy and Immunology Outpatient Progress note |  |  | 
 10044-6 | S wave amplitude in lead V5 |  |  | 
 100440-7 | Allergy Outpatient Progress note |  |  | 
 100441-5 | Attending Outpatient Progress note |  |  | 
 100442-3 | Audiology Outpatient Progress note |  |  | 
 100443-1 | Bariatric surgery Outpatient Progress note |  |  | 
 100444-9 | Blood banking and transfusion medicine Outpatient Progress note |  |  | 
 100445-6 | Bone Marrow Transplant Outpatient Progress note |  |  | 
 100446-4 | Breastfeeding Outpatient Progress note |  |  | 
 100447-2 | Burn management Outpatient Progress note |  |  | 
 100448-0 | Cardiac surgery Outpatient Progress note |  |  | 
 100449-8 | Cardiopulmonary Outpatient Progress note |  |  | 
 10045-3 | S wave amplitude in lead V6 |  |  | 
 100450-6 | Child and adolescent psychiatry Outpatient Progress note |  |  | 
 100451-4 | Chiropractic medicine Outpatient Progress note |  |  | 
 100452-2 | Clinical cardiac electrophysiology Outpatient Progress note |  |  | 
 100453-0 | Clinical genetics Outpatient Progress note |  |  | 
 100454-8 | Clinical neurophysiology Outpatient Progress note |  |  | 
 100455-5 | Clinical pathology Outpatient Progress note |  |  | 
 100456-3 | Colon and rectal surgery Outpatient Progress note |  |  | 
 100457-1 | Consultant Outpatient Progress note |  |  | 
 100458-9 | Outpatient COVID-19 Intubation Progress note |  |  | 
 100459-7 | Outpatient COVID-19 Progress note |  |  | 
 10046-1 | S wave duration in lead AVF |  |  | 
 100460-5 | Dermatology Outpatient Progress note |  |  | 
 100461-3 | Developmental-behavioral pediatrics Outpatient Progress note |  |  | 
 100462-1 | Dialysis and Therapeutic apheresis Outpatient Progress note |  |  | 
 100463-9 | Eating disorders Outpatient Progress note |  |  | 
 100464-7 | Endocrinology Outpatient Progress note |  |  | 
 100465-4 | Family medicine Outpatient Progress note |  |  | 
 100466-2 | Gastroenterology Outpatient Progress note |  |  | 
 100467-0 | Geriatric medicine Outpatient Progress note |  |  | 
 100468-8 | Gynecologic oncology Outpatient Progress note |  |  | 
 100469-6 | Gynecology Outpatient Progress note |  |  | 
 10047-9 | S wave duration in lead AVL |  |  | 
 100470-4 | Healthcare navigator Outpatient Progress note |  |  | 
 100471-2 | Heart failure Outpatient Progress note |  |  | 
 100472-0 | Heart failure+Transplant cardiology Outpatient Progress note |  |  | 
 100473-8 | Hematology Outpatient Progress note |  |  | 
 100474-6 | Hematology+Medical oncology Outpatient Progress note |  |  | 
 100475-3 | Hepatology Outpatient Progress note |  |  | 
 100476-1 | Immunology Outpatient Progress note |  |  | 
 100477-9 | Infectious disease Outpatient Progress note |  |  | 
 100478-7 | Internal medicine Outpatient Progress note |  |  | 
 100479-5 | Interventional cardiology Outpatient Progress note |  |  | 
 10048-7 | S wave duration in lead AVR |  |  | 
 100480-3 | Interventional radiology Outpatient Progress note |  |  | 
 100481-1 | Outpatient Mechanical circulatory support Progress note |  |  | 
 100482-9 | Medical Aid in Dying Outpatient Progress note |  |  | 
 100483-7 | Mental health Outpatient Progress note |  |  | 
 100484-5 | Multi-specialty program Outpatient Progress note |  |  | 
 100485-2 | Neonatal perinatal medicine Outpatient Progress note |  |  | 
 100486-0 | Nephrology Outpatient Progress note |  |  | 
 100487-8 | Neurological surgery Outpatient Progress note |  |  | 
 100488-6 | Neurology Outpatient Progress note |  |  | 
 100489-4 | Neurology with special qualifications in child neurology Outpatient Progress note |  |  | 
 10049-5 | S wave duration in lead I |  |  | 
 100490-2 | Nurse practitioner Outpatient Progress note |  |  | 
 100491-0 | Nurse Outpatient Progress note |  |  | 
 100492-8 | Nutrition and dietetics Outpatient Progress note |  |  | 
 100493-6 | Obstetrics and Gynecology Outpatient Progress note |  |  | 
 100494-4 | Obstetrics Outpatient Progress note |  |  | 
 100495-1 | Occupational therapy Outpatient Progress note |  |  | 
 100496-9 | Oncology Outpatient Progress note |  |  | 
 100497-7 | Ophthalmology Outpatient Progress note |  |  | 
 100498-5 | Optometry Outpatient Progress note |  |  | 
 100499-3 | Oral and Maxillofacial Surgery Outpatient Progress note |  |  | 
 1005-8 | Indirect antiglobulin test.IgG specific reagent [Presence] in Serum or Plasma |  | 
 10050-3 | S wave duration in lead II |  |  | 
 100500-8 | Orthopaedic surgery Outpatient Progress note |  |  | 
 100501-6 | Orthotics prosthetics Outpatient Progress note |  |  | 
 100502-4 | Otolaryngology Outpatient Progress note |  |  | 
 100503-2 | Pain medicine Outpatient Progress note |  |  | 
 100504-0 | Palliative care Outpatient Progress note |  |  | 
 100505-7 | Pediatric cardiology Outpatient Progress note |  |  | 
 100506-5 | Pediatric dermatology Outpatient Progress note |  |  | 
 100507-3 | Pediatric endocrinology Outpatient Progress note |  |  | 
 100508-1 | Pediatric gastroenterology Outpatient Progress note |  |  | 
 100509-9 | Pediatric hematology-oncology Outpatient Progress note |  |  | 
 10051-1 | S wave duration in lead III |  |  | 
 100510-7 | Pediatric infectious diseases Outpatient Progress note |  |  | 
 100511-5 | Pediatric otolaryngology Outpatient Progress note |  |  | 
 100512-3 | Pediatric pulmonology Outpatient Progress note |  |  | 
 100513-1 | Pediatric rheumatology Outpatient Progress note |  |  | 
 100514-9 | Pediatric surgery Outpatient Progress note |  |  | 
 100515-6 | Pediatric transplant hepatology Outpatient Progress note |  |  | 
 100516-4 | Pediatric urology Outpatient Progress note |  |  | 
 100517-2 | Pharmacogenomics Outpatient Progress note |  |  | 
 100518-0 | Physical medicine and rehab Outpatient Progress note |  |  | 
 100519-8 | Physical therapy Outpatient Progress note |  |  | 
 10052-9 | S wave duration in lead V1 |  |  | 
 100520-6 | Plastic surgery Outpatient Progress note |  |  | 
 100521-4 | Podiatry Outpatient Progress note |  |  | 
 100522-2 | Psychiatry Hospital Progress note |  |  | 
 100523-0 | Psychology Outpatient Progress note |  |  | 
 100524-8 | Pulmonary Outpatient Progress note |  |  | 
 100525-5 | Radiation oncology Outpatient Progress note |  |  | 
 100526-3 | Radiology Outpatient Progress note |  |  | 
 100527-1 | Recreational therapy Outpatient Progress note |  |  | 
 100528-9 | Reproductive endocrinology and infertility Outpatient Progress note |  |  | 
 100529-7 | Research Outpatient Progress note |  |  | 
 10053-7 | S wave duration in lead V2 |  |  | 
 100530-5 | Rheumatology Outpatient Progress note |  |  | 
 100531-3 | Sleep medicine Outpatient Progress note |  |  | 
 100532-1 | Social worker Outpatient Progress note |  |  | 
 100533-9 | Solid Organ Transplant Outpatient Progress note |  |  | 
 100534-7 | Speech-language pathology Outpatient Progress note |  |  | 
 100535-4 | Spinal surgery Outpatient Progress note |  |  | 
 100536-2 | Sports medicine Outpatient Progress note |  |  | 
 100537-0 | Surgery of the hand Outpatient Progress note |  |  | 
 100538-8 | Telehealth+Outpatient Progress note |  |  | 
 100539-6 | Thromboembolism Outpatient Progress note |  |  | 
 10054-5 | S wave duration in lead V3 |  |  | 
 100540-4 | Transplant surgery Outpatient Progress note |  |  | 
 100541-2 | Trauma Outpatient Progress note |  |  | 
 100542-0 | Urology Outpatient Progress note |  |  | 
 100543-8 | Vascular neurology Outpatient Progress note |  |  | 
 100544-6 | Vascular surgery Outpatient Progress note |  |  | 
 100545-3 | Wound care management Outpatient Progress note |  |  | 
 100546-1 | Wound, Ostomy, and Continence Care Outpatient Progress note |  |  | 
 100547-9 | Adolescent medicine Hospital Progress note |  |  | 
 100548-7 | Allergy and Immunology Hospital Progress note |  |  | 
 100549-5 | Allergy Hospital Progress note |  |  | 
 10055-2 | S wave duration in lead V4 |  |  | 
 100550-3 | Attending Hospital Progress note |  |  | 
 100551-1 | Audiology Hospital Progress note |  |  | 
 100552-9 | Bariatric surgery Hospital Progress note |  |  | 
 100553-7 | Blood banking and transfusion medicine Hospital Progress note |  |  | 
 100554-5 | Bone Marrow Transplant Hospital Progress note |  |  | 
 100555-2 | Breastfeeding Hospital Progress note |  |  | 
 100556-0 | Burn management Hospital Progress note |  |  | 
 100557-8 | Cardiac surgery Hospital Progress note |  |  | 
 100558-6 | Cardiopulmonary Hospital Progress note |  |  | 
 100559-4 | Child and adolescent psychiatry Hospital Progress note |  |  | 
 10056-0 | S wave duration in lead V5 |  |  | 
 100560-2 | Clinical cardiac electrophysiology Hospital Progress note |  |  | 
 100561-0 | Clinical genetics Hospital Progress note |  |  | 
 100562-8 | Clinical neurophysiology Hospital Progress note |  |  | 
 100563-6 | Clinical pathology Hospital Progress note |  |  | 
 100564-4 | Colon and rectal surgery Hospital Progress note |  |  | 
 100565-1 | Consultant Hospital Progress note |  |  | 
 100566-9 | Dentistry Hospital Progress note |  |  | 
 100567-7 | Dermatology Hospital Progress note |  |  | 
 100568-5 | Developmental-behavioral pediatrics Hospital Progress note |  |  | 
 100569-3 | Dialysis and Therapeutic apheresis Hospital Progress note |  |  | 
 10057-8 | S wave duration in lead V6 |  |  | 
 100570-1 | Eating disorders Hospital Progress note |  |  | 
 100571-9 | Endocrinology Hospital Progress note |  |  | 
 100572-7 | Family medicine Hospital Progress note |  |  | 
 100573-5 | Gastroenterology Hospital Progress note |  |  | 
 100574-3 | General medicine Hospital Progress note |  |  | 
 100575-0 | Geriatric medicine Hospital Progress note |  |  | 
 100576-8 | Gynecologic oncology Hospital Progress note |  |  | 
 100577-6 | Gynecology Hospital Progress note |  |  | 
 100578-4 | Healthcare navigator Hospital Progress note |  |  | 
 100579-2 | Heart failure Hospital Progress note |  |  | 
 10058-6 | S' wave amplitude in lead AVF |  |  | 
 100580-0 | Heart failure+Transplant cardiology Hospital Progress note |  |  | 
 100581-8 | Hematology Hospital Progress note |  |  | 
 100582-6 | Hematology+Medical oncology Hospital Progress note |  |  | 
 100583-4 | Hepatology Hospital Progress note |  |  | 
 100584-2 | Immunology Hospital Progress note |  |  | 
 100585-9 | Infectious disease Hospital Progress note |  |  | 
 100586-7 | Internal medicine Hospital Progress note |  |  | 
 100587-5 | Interventional cardiology Hospital Progress note |  |  | 
 100588-3 | Interventional radiology Hospital Progress note |  |  | 
 100589-1 | Hospital Mechanical circulatory support Progress note |  |  | 
 10059-4 | S' wave amplitude in lead AVL |  |  | 
 100590-9 | Medical Aid in Dying Hospital Progress note |  |  | 
 100591-7 | Mental health Hospital Progress note |  |  | 
 100592-5 | Multi-specialty program Hospital Progress note |  |  | 
 100593-3 | Neonatal perinatal medicine Hospital Progress note |  |  | 
 100594-1 | Nephrology Hospital Progress note |  |  | 
 100595-8 | Neurological surgery Hospital Progress note |  |  | 
 100596-6 | Neurology Hospital Progress note |  |  | 
 100597-4 | Neurology with special qualifications in child neurology Hospital Progress note |  |  | 
 100598-2 | Nurse practitioner Hospital Progress note |  |  | 
 100599-0 | Nurse Hospital Progress note |  |  | 
 1006-6 | Direct antiglobulin test.IgG specific reagent [Interpretation] on Red Blood Cells |  | 
 10060-2 | S' wave amplitude in lead AVR |  |  | 
 100600-6 | Nutrition and dietetics Hospital Progress note |  |  | 
 100601-4 | Obstetrics and Gynecology Hospital Progress note |  |  | 
 100602-2 | Obstetrics Hospital Progress note |  |  | 
 100603-0 | Occupational therapy Hospital Progress note |  |  | 
 100604-8 | Oncology Hospital Progress note |  |  | 
 100605-5 | Ophthalmology Hospital Progress note |  |  | 
 100606-3 | Oral and Maxillofacial Surgery Hospital Progress note |  |  | 
 100607-1 | Orthopaedic surgery Hospital Progress note |  |  | 
 100608-9 | Orthotics prosthetics Hospital Progress note |  |  | 
 100609-7 | Otolaryngology Hospital Progress note |  |  | 
 10061-0 | S' wave amplitude in lead I |  |  | 
 100610-5 | Pain medicine Hospital Progress note |  |  | 
 100611-3 | Palliative care Hospital Progress note |  |  | 
 100612-1 | Pastoral care Hospital Progress note |  |  | 
 100613-9 | Pediatric cardiology Hospital Progress note |  |  | 
 100614-7 | Pediatric dermatology Hospital Progress note |  |  | 
 100615-4 | Pediatric endocrinology Hospital Progress note |  |  | 
 100616-2 | Pediatric gastroenterology Hospital Progress note |  |  | 
 100617-0 | Pediatric hematology-oncology Hospital Progress note |  |  | 
 100618-8 | Pediatric infectious diseases Hospital Progress note |  |  | 
 100619-6 | Pediatric otolaryngology Hospital Progress note |  |  | 
 10062-8 | S' wave amplitude in lead II |  |  | 
 100620-4 | Pediatric pulmonology Hospital Progress note |  |  | 
 100621-2 | Pediatric rheumatology Hospital Progress note |  |  | 
 100622-0 | Pediatric surgery Hospital Progress note |  |  | 
 100623-8 | Pediatric transplant hepatology Hospital Progress note |  |  | 
 100624-6 | Pharmacogenomics Hospital Progress note |  |  | 
 100625-3 | Pharmacology Hospital Progress note |  |  | 
 100626-1 | Physical medicine and rehab Hospital Progress note |  |  | 
 100627-9 | Physical therapy Hospital Progress note |  |  | 
 100628-7 | Plastic surgery Hospital Progress note |  |  | 
 100629-5 | Podiatry Hospital Progress note |  |  | 
 10063-6 | S' wave amplitude in lead III |  |  | 
 100630-3 | Psychology Hospital Progress note |  |  | 
 100631-1 | Radiation oncology Hospital Progress note |  |  | 
 100632-9 | Radiology Hospital Progress note |  |  | 
 100633-7 | Rapid response team Hospital Progress note |  |  | 
 100634-5 | Recreational therapy Hospital Progress note |  |  | 
 100635-2 | Reproductive endocrinology and infertility Hospital Progress note |  |  | 
 100636-0 | Research Hospital Progress note |  |  | 
 100637-8 | Rheumatology Hospital Progress note |  |  | 
 100638-6 | Sleep medicine Hospital Progress note |  |  | 
 100639-4 | Social worker Hospital Progress note |  |  | 
 10064-4 | S' wave amplitude in lead V1 |  |  | 
 100640-2 | Solid Organ Transplant Hospital Progress note |  |  | 
 100641-0 | Speech-language pathology Hospital Progress note |  |  | 
 100642-8 | Spinal surgery Hospital Progress note |  |  | 
 100643-6 | Surgery of the hand Hospital Progress note |  |  | 
 100644-4 | Thromboembolism Hospital Progress note |  |  | 
 100645-1 | Trauma Hospital Progress note |  |  | 
 100646-9 | Urology Hospital Progress note |  |  | 
 100647-7 | Vascular neurology Hospital Progress note |  |  | 
 100648-5 | Vascular surgery Hospital Progress note |  |  | 
 100649-3 | Wound care management Hospital Progress note |  |  | 
 10065-1 | S' wave amplitude in lead V2 |  |  | 
 100650-1 | Wound, Ostomy, and Continence Care Hospital Progress note |  |  | 
 100651-9 | Hospital COVID-19 Intubation Progress note |  |  | 
 100652-7 | Pure tone bone conduction threshold audiometry panel |  |  | 
 100653-5 | Pure tone air conduction threshold audiometry panel |  |  | 
 100654-3 | Pyruvate kinase M2 [Presence] in Stool |  | 
 100655-0 | XR Sella turcica Lateral |  |  | 
 100656-8 | Maternal and fetal medicine Outpatient Progress note |  |  | 
 100657-6 | Maternal and fetal medicine Telephone encounter+Hospital Progress note |  |  | 
 100658-4 | Hospital COVID-19 Progress note |  |  | 
 100659-2 | Maternal and fetal medicine Hospital Progress note |  |  | 
 10066-9 | S' wave amplitude in lead V3 |  |  | 
 100660-0 | Maternal and fetal medicine Telephone encounter+Outpatient Progress note |  |  | 
 100661-8 | Psychiatry Outpatient Progress note |  |  | 
 100662-6 | Cortisol free and total panel - Serum or Plasma |  | 
 100663-4 | TPMT gene c.460G>A and c.719A>G [Presence] in Blood by Molecular genetics method |  | 
 100664-2 | NUDT15 gene c.50_55dup and c.415C>T [Presence] in Blood by Molecular genetics method |  | 
 100665-9 | NUDT15 gene c.415C>T [Presence] in Blood by Molecular genetics method |  | 
 100666-7 | NUDT15 gene c.416G>A [Presence] in Blood by Molecular genetics method |  | 
 100667-5 | NUDT15 gene c.52G>A [Presence] in Blood by Molecular genetics method |  | 
 100668-3 | NUDT15 gene c.50_55dup [Presence] in Blood by Molecular genetics method |  | 
 100669-1 | NUDT15 gene c.50_55del [Presence] in Blood by Molecular genetics method |  | 
 10067-7 | S' wave amplitude in lead V4 |  |  | 
 100670-9 | RHD gene allele [Identifier] in Plasma cell-free DNA Nominal--fetus |  | 
 100671-7 | Aspergillus sp DNA [Presence] in Blood by NAA with probe detection |  | 
 100672-5 | Aspergillus fumigatus DNA [Presence] in Blood by NAA with probe detection |  | 
 100673-3 | Aspergillus terreus DNA [Presence] in Blood by NAA with probe detection |  | 
 100674-1 | BK virus DNA [Log #/volume] (viral load) in Blood by NAA with probe detection |  | 
 100675-8 | Cytomegalovirus DNA [Units/volume] (viral load) in Blood by NAA with probe detection |  | 
 100676-6 | Cytomegalovirus DNA [log units/volume] (viral load) in Blood by NAA with probe detection |  | 
 100677-4 | Epstein Barr virus DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection |  | 
 100678-2 | Epstein Barr virus DNA [Log #/volume] (viral load) in Blood by NAA with probe detection |  | 
 100679-0 | Herpes virus 6 DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection |  | 
 10068-5 | S' wave amplitude in lead V5 |  |  | 
 100680-8 | Herpes virus 6 DNA [Log #/volume] (viral load) in Blood by NAA with probe detection |  | 
 100681-6 | Herpes virus 7 DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection |  | 
 100682-4 | Herpes virus 7 DNA [Log #/volume] (viral load) in Blood by NAA with probe detection |  | 
 100683-2 | Herpes virus 8 DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection |  | 
 100684-0 | Herpes virus 8 DNA [Log #/volume] (viral load) in Blood by NAA with probe detection |  | 
 100685-7 | JC virus DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection |  | 
 100686-5 | JC virus DNA [Log #/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection |  | 
 100687-3 | JC virus DNA [Log #/volume] (viral load) in Urine by NAA with probe detection |  | 
 100688-1 | Parvovirus B19 DNA [Log #/volume] (viral load) in Blood by NAA with probe detection |  | 
 100689-9 | Toxoplasma gondii DNA [Log #/volume] in Serum or Plasma by NAA with probe detection |  | 
 10069-3 | S' wave amplitude in lead V6 |  |  | 
 100690-7 | Toxoplasma gondii DNA [Log #/volume] in Cerebral spinal fluid by NAA with probe detection |  | 
 100691-5 | Varicella zoster virus DNA [Log #/volume] (viral load) in Blood by NAA with probe detection |  | 
 100692-3 | Varicella zoster virus DNA [Log #/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection |  | 
 100693-1 | Pneumocystis jiroveci DNA [Log #/volume] in Respiratory specimen by NAA with probe detection |  | 
 100694-9 | SMN1 gene silent carrier analysis [Presence] in Blood or Tissue by Molecular genetics method |  | 
 100695-6 | Genetic disease analysis overall carrier interpretation in Blood or Tissue by Molecular genetics method Narrative |  | 
 100696-4 | CTNS related multigene analysis [Identifier] in Bodyfluid and Serum or Plasma by Molecular genetics method Nominal |  | 
 100697-2 | Interventional radiology Outpatient Note |  |  | 
 100698-0 | Social Determinants of Health screening report Document |  |  | 
 100699-8 | Rifabutin+Ethambutol [Susceptibility] |  | 
 1007-4 | Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells |  | 
 10070-1 | S' wave duration in lead AVF |  |  | 
 100700-4 | Trichomonas vaginalis DNA [Presence] in Urethra by NAA with probe detection |  | 
 100701-2 | Trichomonas vaginalis rRNA [Presence] in Urethra by NAA with probe detection |  | 
 100702-0 | Mycoplasma genitalium rRNA [Presence] in Urethra by NAA with probe detection |  | 
 100703-8 | Mycoplasma genitalium rRNA [Presence] in Urine by NAA with probe detection |  | 
 100704-6 | Mycoplasma genitalium rRNA [Presence] in Cervix by NAA with probe detection |  | 
 100705-3 | Mycoplasma genitalium rRNA [Presence] in Anorectal by NAA with probe detection |  | 
 100706-1 | Mycoplasma genitalium rRNA [Presence] in Specimen by NAA with probe detection |  | 
 100707-9 | Polymorphonuclear cells [#/volume] in Peritoneal dialysis fluid by Automated count |  | 
 100708-7 | Plasma cells/100 leukocytes in Synovial fluid |  | 
 100709-5 | Hepatocellular carcinoma risk [Score] by GAAD |  | 
 10071-9 | S' wave duration in lead AVL |  |  | 
 100710-3 | Chlamydia trachomatis and Neisseria gonorrhoeae rRNA panel - Throat by NAA with probe detection |  | 
 100711-1 | Borrelia burgdorferi.VlsE1+pepC10 Ab [Units/volume] in Serum by Immunoassay |  | 
 100712-9 | Brexpiprazole [Mass/volume] in Serum or Plasma |  | 
 100713-7 | Cariprazine [Mass/volume] in Serum or Plasma |  | 
 100714-5 | Guanfacine [Mass/volume] in Serum or Plasma |  | 
 100715-2 | Prothipendyl [Mass/volume] in Serum or Plasma |  | 
 100716-0 | Prostate specific Ag [Mass/volume] in DBS |  | 
 100717-8 | FCGR3A gene.p.Phe176Val [Presence] in Blood or Tissue by Molecular genetics method |  | 
 100718-6 | Undersea and hyperbaric medicine Discharge summary |  |  | 
 100719-4 | Surgical oncology Discharge summary |  |  | 
 10072-7 | S' wave duration in lead AVR |  |  | 
 100720-2 | Reproductive endocrinology and infertility Discharge summary |  |  | 
 100721-0 | Community health care Discharge summary |  |  | 
 100722-8 | Integrative medicine Discharge summary |  |  | 
 100723-6 | Sports medicine Discharge summary |  |  | 
 100724-4 | Diabetology Discharge summary |  |  | 
 100725-1 | Optometry Discharge summary |  |  | 
 100726-9 | Podiatry Discharge summary |  |  | 
 100727-7 | Chiropractic medicine Discharge summary |  |  | 
 100728-5 | Cardiac surgery Discharge summary |  |  | 
 100729-3 | Breastfeeding Discharge summary |  |  | 
 10073-5 | S' wave duration in lead I |  |  | 
 100730-1 | Transplant surgery Discharge summary |  |  | 
 100731-9 | Urgent care center Discharge summary |  |  | 
 100732-7 | Cholesterol.in lipoprotein (little a) and Cholesterol.in LDL panel - Serum |  | 
 100733-5 | Cholesterol in LDL [Mass/volume] in Serum by calculation --corrected for Cholesterol.in lipoprotein (little a) |  | 
 100734-3 | traMADol and Metabolites Panel - Urine by Confirmatory method |  | 
 100735-0 | Mannose-6-phosphate isomerase and phosphomannomutase 1 panel - Leukocytes |  | 
 100736-8 | Acylcarnitine Analysis Post Mortem in Specimen Document |  | 
 100737-6 | Alkaline phosphatase.macromolecular [Presence] in Serum or Plasma |  | 
 100738-4 | Alanine aminotransferase.macromolecular [Presence] in Serum or Plasma |  | 
 100739-2 | Aspartate aminotransferase.macromolecular [Presence] in Serum or Plasma |  | 
 10074-3 | S' wave duration in lead II |  |  | 
 100740-0 | Amylase.macromolecular [Presence] in Serum or Plasma |  | 
 100741-8 | Gamma glutamyl transferase.macromolecular [Presence] in Serum or Plasma |  | 
 100742-6 | Lactate dehydrogenase.macromolecular [Presence] in Serum or Plasma |  | 
 100743-4 | Lipase.macromolecular [Presence] in Serum or Plasma |  | 
 100744-2 | Alpha-1-acid glycoprotein [Mass/volume] in Serum or Plasma by Electrophoresis |  | 
 100745-9 | Chloride [Moles/volume] in Mixed venous blood |  | 
 100746-7 | Glucose [Moles/volume] in Mixed venous blood |  | 
 100747-5 | Legionella serogroup panel - Specimen |  | 
 100748-3 | Legionella spp [Presence] in Specimen by NAA with probe detection |  | 
 100749-1 | Legionella pneumophila serogroup 1 [Presence] in Specimen by NAA with probe detection |  | 
 10075-0 | S' wave duration in lead III |  |  | 
 100750-9 | Legionella pneumophila non-serogroup 1 [Presence] in Specimen by NAA with probe detection |  | 
 100751-7 | Galactose-alpha-1,3-galactose (Alpha-Gal) panel - Serum or Plasma |  | 
 100752-5 | Exacerbating factors - Reported |  |  | 
 100753-3 | Alleviating factors - Reported |  |  | 
 100754-1 | Platelet disorders multigene analysis in Blood or Tissue by Sequencing |  | 
 100755-8 | Oligoclonal bands [#] in Serum or Plasma by Isoelectric focusing |  | 
 100756-6 | Oligoclonal bands [Interpretation] in Cerebral spinal fluid by Isoelectric focusing |  | 
 100757-4 | Protein fractions.oligoclonal bands panel - Serum and CSF by Isoelectric focusing |  | 
 100758-2 | Estimated lung age by based on clinical data |  |  | 
 100759-0 | Inspiratory reserve [Volume] Respiratory system by Spirometry |  |  | 
 10076-8 | S' wave duration in lead V1 |  |  | 
 100760-8 | XR Radius and Ulna - left Single view |  |  | 
 100761-6 | PALB2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |  | 
 100762-4 | HBA2 gene.c.377T>C [Presence] in Blood by Molecular genetics method |  | 
 100763-2 | Mycobacterium sp comparative reaction interpretation Narrative |  | 
 100764-0 | Mycobacterium bovis reaction wheal [Diameter] Qualitative --3 days post dose mammalian tuberculin intradermal |  | 
 100765-7 | Homocysteine and methylmalonate and methylcitrate panel - DBS |  | 
 100766-5 | Center for Epidemiologic Studies Depression Scale panel [CES-D] |  |  | 
 100767-3 | Bothered by things that are not usually bothersome |  |  | 
 100768-1 | Poor appetite |  |  | 
 100769-9 | Unhappy even with help from my family or friends |  |  | 
 10077-6 | S' wave duration in lead V2 |  |  | 
 100770-7 | Feeling just as good as others |  |  | 
 100771-5 | Trouble focusing |  |  | 
 100772-3 | Feeling depressed |  |  | 
 100773-1 | Feeling everything is too much of an effort |  |  | 
 100774-9 | Feeling hopeful about the future |  |  | 
 100775-6 | Feeling life had been a failure |  |  | 
 100776-4 | Feeling fearful |  |  | 
 100777-2 | Restless sleep |  |  | 
 100778-0 | Feeling happy |  |  | 
 100779-8 | Quieter than usual |  |  | 
 10078-4 | S' wave duration in lead V3 |  |  | 
 100780-6 | Feeling lonely |  |  | 
 100781-4 | People were unfriendly |  |  | 
 100782-2 | Enjoying life |  |  | 
 100783-0 | Crying spells |  |  | 
 100784-8 | Feeling sad |  |  | 
 100785-5 | Feeling people dislike me |  |  | 
 100786-3 | Lack of energy |  |  | 
 100787-1 | Total Score CES-D |  |  | 
 100788-9 | Stemphylium botryosum IgG4 Ab [Mass/volume] in Serum |  | 
 100789-7 | Rhizopus nigricans IgG4 Ab [Mass/volume] in Serum |  | 
 10079-2 | S' wave duration in lead V4 |  |  | 
 100790-5 | Lepidoglyphus destructor IgG Ab [Mass/volume] in Serum |  | 
 100791-3 | Hamster epithelium IgG Ab [Mass/volume] in Serum |  | 
 100792-1 | Forsythia IgE Ab [Units/volume] in Serum |  | 
 100793-9 | Testosterone [Mass/volume] in Body fluid |  | 
 100794-7 | Follitropin [Units/volume] in Body fluid |  | 
 100795-4 | S100 calcium binding protein B [Mass/volume] in Body fluid |  | 
 100796-2 | Thyroglobulin [Mass/volume] in Body fluid |  | 
 100797-0 | Testosterone Free [Mass/volume] in Serum --1st specimen post XXX challenge |  | 
 100798-8 | Testosterone Free [Mass/volume] in Serum --2nd specimen post XXX challenge |  | 
 100799-6 | 21-Deoxycortisol [Mass/volume] in Serum --1st specimen post XXX challenge |  | 
 1008-2 | Indirect antiglobulin test.polyspecific reagent [Presence] in Serum or Plasma |  | 
 10080-0 | S' wave duration in lead V5 |  |  | 
 100800-2 | 21-Deoxycortisol [Mass/volume] in Serum --2nd specimen post XXX challenge |  | 
 100801-0 | 21-Deoxycortisol [Mass/volume] in Serum --3rd specimen post XXX challenge |  | 
 100802-8 | 21-Deoxycortisol [Mass/volume] in Serum --4th specimen post XXX challenge |  | 
 100803-6 | 21-Deoxycortisol [Mass/volume] in Serum --5th specimen post XXX challenge |  | 
 100804-4 | Vasopressin [Moles/volume] in Plasma --1st specimen post XXX challenge |  | 
 100805-1 | Vasopressin [Moles/volume] in Plasma --2nd specimen post XXX challenge |  | 
 100806-9 | Vasopressin [Moles/volume] in Plasma --3rd specimen post XXX challenge |  | 
 100807-7 | Vasopressin [Moles/volume] in Plasma --4th specimen post XXX challenge |  | 
 100808-5 | Vasopressin [Moles/volume] in Plasma --5th specimen post XXX challenge |  | 
 100809-3 | Vasopressin [Moles/volume] in Plasma --6th specimen post XXX challenge |  | 
 10081-8 | S' wave duration in lead V6 |  |  | 
 100810-1 | Vasopressin [Moles/volume] in Plasma --7th specimen post XXX challenge |  | 
 100811-9 | Vasopressin [Moles/volume] in Plasma --8th specimen post XXX challenge |  | 
 100812-7 | Vasopressin [Moles/volume] in Plasma --9th specimen post XXX challenge |  | 
 100813-5 | Vasopressin [Moles/volume] in Plasma --10th specimen post XXX challenge |  | 
 100814-3 | Vasopressin [Moles/volume] in Plasma --11th specimen post XXX challenge |  | 
 100815-0 | Vasopressin [Moles/volume] in Plasma --12th specimen post XXX challenge |  | 
 100816-8 | Glucagon [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge |  | 
 100817-6 | Glucagon [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge |  | 
 100818-4 | Renin [Mass/volume] in Plasma --1st specimen post XXX challenge |  | 
 100819-2 | Renin [Mass/volume] in Plasma --2nd specimen post XXX challenge |  | 
 10082-6 | ST initial amplitude 6 ms in lead AVF |  |  | 
 100820-0 | Renin [Mass/volume] in Plasma --3rd specimen post XXX challenge |  | 
 100821-8 | National POLST form: portable medical order panel |  |  | 
 100822-6 | Cardiopulmonary resuscitation orders |  |  | 
 100823-4 | Initial portable medical treatment orders |  |  | 
 100824-2 | Additional portable medical orders or instructions |  |  | 
 100825-9 | Medically assisted nutrition orders |  |  | 
 100826-7 | Portable medical order AndOr advance directive review |  |  | 
 100827-5 | Portable medical order discussion participants |  |  | 
 100828-3 | Portable medical order administrative information |  |  | 
 100829-1 | Renin [Mass/volume] in Plasma --4th specimen post XXX challenge |  | 
 10083-4 | ST initial amplitude 6 ms in lead AVL |  |  | 
 100830-9 | Alpha subunit free [Units/volume] in Serum or Plasma --1st specimen post XXX challenge |  | 
 100831-7 | Alpha subunit free [Units/volume] in Serum or Plasma --2nd specimen post XXX challenge |  | 
 100832-5 | Alpha subunit free [Units/volume] in Serum or Plasma --3rd specimen post XXX challenge |  | 
 100833-3 | Alpha subunit free [Units/volume] in Serum or Plasma --4th specimen post XXX challenge |  | 
 100834-1 | Alpha subunit free [Units/volume] in Serum or Plasma --5th specimen post XXX challenge |  | 
 100835-8 | Alpha subunit free [Units/volume] in Serum or Plasma --6th specimen post XXX challenge |  | 
 100836-6 | Alpha subunit free [Units/volume] in Serum or Plasma --7th specimen post XXX challenge |  | 
 100837-4 | Insulin-like growth factor-I [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge |  | 
 100838-2 | Testosterone [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge |  | 
 100839-0 | Vitamin A/Retinol binding protein [Ratio] in Serum or Plasma |  | 
 10084-2 | ST initial amplitude 6 ms in lead AVR |  |  | 
 100840-8 | IgE [Units/volume] in Body fluid |  | 
 100841-6 | Zinc finger protein of the cerebellum 4 Ab [Presence] in Cerebral spinal fluid by Line blot |  | 
 100842-4 | Nonalcoholic steatohepatitis score in Serum or Plasma Calculated by FAST |  | 
 100843-2 | Liver fibrosis score in Serum or Plasma by Calculated.Agile3+ |  | 
 100844-0 | Liver fibrosis score in Serum or Plasma by Calculated.Agile4 |  | 
 100845-7 | Neurofascin155 IgG4 Ab [Presence] in Serum by Flow cytometry (FC) |  | 
 100846-5 | Dengue virus 1+2+3+4 nsP1 IgG Ab [Presence] in Serum or Plasma by Immunoassay |  | 
 100847-3 | Gas and ammonia panel - Arterial blood |  | 
 100848-1 | Cell count and Differential panel - Amniotic fluid by Manual count |  | 
 100849-9 | Leukocytes [#/volume] in Amniotic fluid by Manual count |  | 
 10085-9 | ST initial amplitude 6 ms in lead I |  |  | 
 100850-7 | Neutrophils [#/volume] in Amniotic fluid by Manual count |  | 
 100851-5 | Other cells [#/volume] in Amniotic fluid by Manual count |  | 
 100852-3 | NM Bones Views for metastasis W Sr-89 IV |  |  | 
 100853-1 | NM Pericardial space Pericardial effusion |  |  | 
 100854-9 | Lymphocytes/100 cells in Blood mononuclear cells by Immunoassay |  | 
 100855-6 | CD3 cells/100 cells in Blood mononuclear cells |  | 
 100856-4 | CD3+CD4+ (T4 helper) cells/100 cells in Blood mononuclear cells |  | 
 100857-2 | CD3+CD8+ (T8 suppressor) cells/100 cells in Blood mononuclear cells |  | 
 100858-0 | Cells.CD4+CD154+/CD4 cells in Blood --after stimulation with SARS-CoV-2 Spike peptide |  | 
 100859-8 | Cells.CD4.Interferon gamma-expressing/CD4 cells in Blood --after stimulation with SARS-CoV-2 Spike peptide |  | 
 10086-7 | ST initial amplitude 6 ms in lead II |  |  | 
 100860-6 | Cells.CD4.Tumor necrosis factor alfa-expressing/CD4 cells in Blood --after stimulation with SARS-CoV-2 Spike peptide |  | 
 100861-4 | Cells.CD4+CD154+/CD4 cells in Blood --after stimulation with SARS-CoV-2 Nucleocapsid peptide |  | 
 100862-2 | Cells.CD4.Interferon gamma-expressing/CD4 cells in Blood --after stimulation with SARS-CoV-2 Nucleocapsid peptide |  | 
 100863-0 | Cells.CD4.Tumor necrosis factor alfa-expressing/CD4 cells in Blood --after stimulation with SARS-CoV-2 Nucleocapsid peptide |  | 
 100864-8 | Giardia lamblia bg gene [Genotype] in Specimen by Molecular genetics method |  | 
 100865-5 | Avian schistosomes DNA [Presence] in Specimen by NAA with probe detection |  | 
 100866-3 | Febrile antibody profile in Serum |  | 
 100867-1 | Campylobacter jejuni+coli+lari+upsaliensis Ag [Presence] in Stool by Rapid immunoassay |  | 
 100868-9 | Cryptosporidium sp 18S-LC2 rRNA [Genotype] in Specimen by Molecular genetics method |  | 
 100869-7 | Cryptosporidium gp60 gene [Type] in Specimen by Molecular genetics method |  | 
 10087-5 | ST initial amplitude 6 ms in lead III |  |  | 
 100870-5 | Cryptosporidium 18S rRNA [Genotype] in Specimen by Molecular genetics method |  | 
 100871-3 | Giardia lamblia gdh gene [Genotype] in Specimen by Molecular genetics method |  | 
 100872-1 | Bacteria producing polysaccharide from sucrose [Presence] in Isolate |  | 
 100873-9 | Giardia lamblia tpi gene [Genotype] in Specimen by Molecular genetics method |  | 
 100874-7 | Basidiobolus sp [Presence] in Specimen |  | 
 100875-4 | Fetal Heart Document limited US |  |  | 
 100876-2 | Fetal Heart Document US |  |  | 
 100877-0 | US Heart Transesophageal during surgery |  |  | 
 100878-8 | Endoscopic ultrasound study Upper GI tract Document |  |  | 
 100879-6 | US Guidance for cryoablation of Breast - right |  |  | 
 10088-3 | ST initial amplitude 6 ms in lead V1 |  |  | 
 100880-4 | US Guidance for cryoablation of Breast - left |  |  | 
 100881-2 | MR Guidance for cryoablation of Bone |  |  | 
 100882-0 | MR Peritoneum W contrast percutaneous intraperitoneal |  |  | 
 100883-8 | MR Guidance for biopsy of Kidney - left |  |  | 
 100884-6 | MR Guidance for biopsy of Kidney - right |  |  | 
 100885-3 | Parapoxvirus DNA [Presence] in Specimen by NAA with probe detection |  | 
 100886-1 | Orf virus DNA [Presence] in Specimen by NAA with probe detection |  | 
 100887-9 | Pseudocowpox virus DNA [Presence] in Specimen by NAA with probe detection |  | 
 100888-7 | West African monkeypox virus DNA [Presence] in Specimen by NAA with probe detection |  | 
 100889-5 | Congo Basin monkeypox virus DNA [Presence] in Specimen by NAA with probe detection |  | 
 10089-1 | ST initial amplitude 6 ms in lead V2 |  |  | 
 100890-3 | Poxvirus DNA panel |  | 
 100891-1 | Orthopoxvirus IgG Ab [Presence] in Serum or Plasma by Immunoassay |  | 
 100892-9 | Orthopoxvirus IgM Ab [Presence] in Serum or Plasma by Immunoassay |  | 
 100893-7 | Orthopoxvirus IgG and IgM Ab panel - Serum or Plasma |  | 
 100894-5 | Recommended screening frequency Narrative |  |  | 
 100895-2 | Rickettsia conorii IgG and IgM [Interpretation] in Serum |  | 
 100896-0 | Vasopressin [Moles/volume] in Plasma --13th specimen post XXX challenge |  | 
 100897-8 | Staphylococcus aureus [Presence] in Specimen by Organism specific culture |  | 
 100898-6 | Lipid panel - Serum or Plasma |  | 
 100899-4 | Enterobacteriaceae.extended spectrum beta lactamase resistance phenotype [Identifier] in Specimen by Organism specific culture |  | 
 1009-0 |  | Deprecated Direct antiglobulin test.poly specific reagent [Presence] on Red Blood Cells |  | 
 100900-0 |  | Enterobacteriaceae.carbapenem resistance panel - Anal by Organism specific culture |  | 
 100901-8 |  | Enterobacteriaceae.carbapenemase resistance phenotype [Identifier] in Anal by Organism specific culture |  | 
 100902-6 |  | Enterobacteriaceae.carbapenemase resistance phenotype.OXA-48 [Identifier] in Anal by Organism specific culture |  | 
 100903-4 |  | Yeast and Candida sp identification panel - Specimen by Organism specific culture |  | 
 100904-2 |  | Urinary tract pathogens panel - Urine by Culture |  | 
 100905-9 |  | Gram positive bacteria identified in Isolate by Organism specific culture |  | 
 100906-7 |  | Bacteria [#/volume] in Urine by Culture |  | 
 100907-5 |  | Vancomycin resistant enterococcus [Identifier] in Specimen by Organism specific culture |  | 
 100908-3 |  | Pseudomonas aeruginosa [Presence] in Lower respiratory specimen by Organism specific culture |  | 
 100909-1 |  | Cronobacter sakazakii [Presence] by Organism specific culture |  | 
 100910-9 |  | Gram negative bacteria.colistin resistant identified in Stool by Organism specific culture |  | 
 100911-7 |  | Campylobacter sp [Presence] in Stool by Organism specific culture |  | 
 100912-5 |  | Enterobacteriaceae.extended spectrum beta lactamase resistance phenotype and Enterococcus species.vancomycin resistant panel |  | 
 100913-3 |  | Staph aureus and MRSA screening panel - Specimen by Organism specific culture |  | 
 100914-1 |  | Protein.abnormal band [Mass/volume] in Serum or Plasma by Electrophoresis |  | 
 100915-8 |  | Burr cells [Presence] in Body fluid by Light microscopy |  | 
 100962-0 |  | Dengue virus Ab.IgG Panel - Serum, Plasma or Blood |  | 
 100963-8 |  | Dengue virus 1+2+3+4 nsP1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay |  | 
 100964-6 |  | Dengue virus IgG Ab [Presence] in Serum, Plasma or Blood by Rapid immunoassay |  | 
 100965-3 |  | Dengue virus IgG Ab [Interpretation] in Serum, Plasma or Blood |  | 
 100968-7 |  | Bovine tuberculosis comparative cervical test panel - Skin |  | 
 101-6 |  | Cefoperazone [Susceptibility] by Disk diffusion (KB) |  | 
 1010-8 |  | E sup(w) Ab [Presence] in Serum or Plasma from Blood product unit |  | 
 1011-6 |  | E sup(w) Ab [Presence] in Serum or Plasma from Donor |  | 
 1012-4 |  | E sup(w) Ab [Presence] in Serum or Plasma |  | 
 1013-2 |  | E sup(w) Ag [Presence] on Red Blood Cells from Blood product unit |  | 
 1014-0 |  | E sup(w) Ag [Presence] on Red Blood Cells from Donor |  | 
 1015-7 |  | E sup(w) Ag [Presence] on Red Blood Cells |  | 
 1016-5 |  | E Ab [Presence] in Serum or Plasma from Blood product unit |  | 
 1017-3 |  | E Ab [Presence] in Serum or Plasma from Donor |  | 
 1018-1 |  | E Ab [Presence] in Serum or Plasma |  | 
 1019-9 |  | E Ag [Presence] on Red Blood Cells from Blood product unit |  | 
 102-4 |  | Cefoperazone [Susceptibility] by Serum bactericidal titer |  | 
 1020-7 |  | E Ag [Presence] on Red Blood Cells from Donor |  | 
 1021-5 |  | E Ag [Presence] on Red Blood Cells |  | 
 1022-3 |  | Fy sup(a) Ab [Presence] in Serum or Plasma from Blood product unit |  | 
 10226-9 |  | Oxygen content in Intravascular space |  | 
 1023-1 |  | Fy sup(a) Ab [Presence] in Serum or Plasma from Donor |  | 
 10232-7 |  | Oxygen content in Aorta root |  | 
 10233-5 |  | Oxygen content in Left atrium |  | 
 10234-3 |  | Oxygen content in Right atrium |  | 
 10235-0 |  | Oxygen content in High right atrium |  | 
 10236-8 |  | Oxygen content in Low right atrium |  | 
 10237-6 |  | Oxygen content in Mid right atrium |  | 
 10238-4 |  | Oxygen content in Left ventricle |  | 
 10239-2 |  | Oxygen content in Right ventricular outflow tract |  | 
 1024-9 |  | Fy sup(a) Ab [Presence] in Serum or Plasma |  | 
 10240-0 |  | Oxygen content in Right ventricle |  | 
 10241-8 |  | Oxygen content in Coronary sinus |  | 
 10242-6 |  | Oxygen content in Ductus arteriosus |  | 
 10243-4 |  | Oxygen content in Inferior vena cava |  | 
 10244-2 |  | Oxygen content in Left pulmonary artery |  | 
 10245-9 |  | Oxygen content in Main pulmonary artery |  | 
 10246-7 |  | Oxygen content in Right pulmonary artery |  | 
 10247-5 |  | Oxygen content in Pulmonary wedge |  | 
 10248-3 |  | Oxygen content in Superior vena cava |  | 
 1025-6 |  | Fy sup(a) Ag [Presence] on Red Blood Cells from Blood product unit |  | 
 1026-4 |  | Fy sup(a) Ag [Presence] on Red Blood Cells from Donor |  | 
 1027-2 |  | Fy sup(a) Ag [Presence] on Red Blood Cells |  | 
 1028-0 |  | Fy sup(b) Ab [Presence] in Serum or Plasma from Blood product unit |  | 
 1029-8 |  | Fy sup(b) Ab [Presence] in Serum or Plasma from Donor |  | 
 103-2 |  | Ceforanide [Susceptibility] by Minimum lethal concentration (MLC) |  | 
 1030-6 |  | Fy sup(b) Ab [Presence] in Serum or Plasma |  | 
 1031-4 |  | Fy sup(b) Ag [Presence] on Red Blood Cells from Blood product unit |  | 
 1032-2 |  | Fy sup(b) Ag [Presence] on Red Blood Cells from Donor |  | 
 10327-5 |  | Eosinophils/100 leukocytes in Sputum by Manual count |  | 
 10328-3 |  | Lymphocytes/100 leukocytes in Cerebral spinal fluid by Manual count |  | 
 10329-1 |  | Monocytes/100 leukocytes in Cerebral spinal fluid by Manual count |  | 
 1033-0 |  | Fy sup(b) Ag [Presence] on Red Blood Cells |  | 
 10330-9 |  | Monocytes/100 leukocytes in Body fluid by Manual count |  | 
 10331-7 |  | Rh [Type] in Blood |  | 
 10332-5 |  | Cortisol [Mass/volume] in Serum or Plasma --pre 250 ug corticotropin IM |  | 
 10333-3 |  | Appearance of Cerebral spinal fluid |  | 
 10334-1 |  | Cancer Ag 125 [Units/volume] in Serum or Plasma |  | 
 10335-8 |  | Color of Cerebral spinal fluid |  | 
 10336-6 |  | Gonadotropin peptide [Mass/volume] in Urine |  | 
 10337-4 |  | Procollagen type I [Mass/volume] in Serum |  | 
 10338-2 |  | Barbiturates [Mass/volume] in Serum or Plasma |  | 
 10339-0 |  | FLUoxetine+Norfluoxetine [Mass/volume] in Serum or Plasma |  | 
 1034-8 |  | Fetal cell screen [Interpretation] in Blood |  | 
 10340-8 |  | Molindone [Mass/volume] in Serum or Plasma |  | 
 10341-6 |  | Norpropoxyphene [Mass/volume] in Serum or Plasma |  | 
 10342-4 |  | Sulfamethoxazole [Mass/volume] in Serum or Plasma |  | 
 10343-2 |  | Temazepam [Mass/volume] in Serum or Plasma |  | 
 10344-0 |  | Tranylcypromine [Mass/volume] in Serum or Plasma |  | 
 10345-7 |  | Trihexyphenidyl [Mass/volume] in Urine |  | 
 10346-5 |  | Hemoglobin A [Units/volume] in Blood by Electrophoresis |  | 
 10347-3 |  | Babesia microti identified in Blood by Light microscopy |  | 
 10348-1 |  | Bordetella parapertussis Ab [Presence] in Serum |  | 
 10349-9 |  | Brucella sp Ab [Units/volume] in Serum |  | 
 1035-5 |  | Fresh frozen plasma given [Volume] |  | 
 10350-7 |  | Herpes simplex virus IgM Ab [Titer] in Serum by Immunoassay |  | 
 10351-5 |  | HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification |  | 
 10352-3 |  | Bacteria identified in Genital specimen by Aerobe culture |  | 
 10353-1 |  | Bacteria identified in Nose by Aerobe culture |  | 
 10354-9 |  | Bacteria identified in Urethra by Culture |  | 
 10355-6 |  | Microscopic observation [Identifier] in Bone marrow by Wright Giemsa stain |  | 
 10356-4 |  | Deprecated Microscopic observation [Identifier] in Stool by Trichrome stain |  | 
 10357-2 |  | Microscopic observation [Identifier] in Wound by Gram stain |  | 
 10358-0 |  | Teichoate Ab [Titer] in Serum by Immune diffusion (ID) |  | 
 10359-8 |  | Asialoganglioside GM1 IgM Ab [Titer] in Serum |  | 
 1036-3 |  | G Ab [Presence] in Serum or Plasma from Blood product unit |  | 
 10360-6 |  | DNA single strand IgG Ab [Units/volume] in Serum |  | 
 10361-4 |  | DNA single strand IgM Ab [Units/volume] in Serum |  | 
 10362-2 |  | Endomysium IgA Ab [Presence] in Serum |  | 
 10363-0 |  | Barbiturates [Presence] in Specimen |  | 
 10364-8 |  | Cotinine [Mass/mass] in Hair |  | 
 10365-5 |  | Cotinine [Mass/volume] in Serum or Plasma |  | 
 10366-3 |  | Cotinine [Mass/volume] in Urine |  | 
 10367-1 |  | Ethanol [Mass/volume] in Gastric fluid |  | 
 10368-9 |  | Lead [Mass/volume] in Capillary blood |  | 
 10369-7 |  | Opiates [Mass/mass] in Hair |  | 
 1037-1 |  | G Ab [Presence] in Serum or Plasma from Donor |  | 
 10370-5 |  | Phencyclidine [Mass/mass] in Hair |  | 
 10371-3 |  | Bite cells [Presence] in Blood by Light microscopy |  | 
 10372-1 |  | Blister cells [Presence] in Blood by Light microscopy |  | 
 10373-9 |  | Fragments [Presence] in Blood by Light microscopy |  | 
 10374-7 |  | Helmet cells [Presence] in Blood by Light microscopy |  | 
 10375-4 |  | Irregularly contracted cells [Presence] in Blood by Light microscopy |  | 
 10376-2 |  | Oval macrocytes [Presence] in Blood by Light microscopy |  | 
 10377-0 |  | Pencil cells [Presence] in Blood by Light microscopy |  | 
 10378-8 |  | Polychromasia [Presence] in Blood by Light microscopy |  | 
 10379-6 |  | Erythrocytes.dual population [Presence] in Blood by Light microscopy |  | 
 1038-9 |  | G Ab [Presence] in Serum or Plasma |  | 
 10380-4 |  | Stomatocytes [Presence] in Blood by Light microscopy |  | 
 10381-2 |  | Target cells [Presence] in Blood by Light microscopy |  | 
 10382-0 |  | Deprecated A,B variant NOS Ag [Presence] on Red Blood Cells from Blood product unit |  | 
 10383-8 |  | Deprecated A,B variant NOS Ag [Presence] on Red Blood Cells from Donor |  | 
 10384-6 |  | Deprecated A,B variant NOS Ag [Presence] on Red Blood Cells |  | 
 10385-3 |  | Albumin concentration given |  | 
 10386-1 |  | Albumin given [Volume] |  | 
 10387-9 |  | Autologous erythrocytes given [Volume] |  | 
 10388-7 |  | Autologous whole blood given [Volume] |  | 
 10389-5 |  | Blood product.other [Type] |  | 
 1039-7 |  | G Ag [Presence] on Red Blood Cells from Blood product unit |  | 
 10390-3 |  | Blood product special preparation [Type] |  | 
 10391-1 |  | Cytomegalovirus immune globulin given [Volume] |  | 
 10392-9 |  | Cryoprecipitate given [Volume] |  | 
 10393-7 |  | Factor IX given [Type] |  | 
 10394-5 |  | Factor IX given [Volume] |  | 
 10395-2 |  | Factor VIII given [Type] |  | 
 10396-0 |  | Factor VIII given [Volume] |  | 
 10397-8 |  | Hepatitis B immune globulin given [Volume] |  | 
 10398-6 |  | I Ag [Presence] on Red Blood Cells from Blood product unit |  | 
 10399-4 |  | I Ag [Presence] on Red Blood Cells from Donor |  | 
 104-0 |  | Ceforanide [Susceptibility] by Minimum inhibitory concentration (MIC) |  | 
 1040-5 |  | G Ag [Presence] on Red Blood Cells from Donor |  | 
 10400-0 |  | I Ag [Presence] on Red Blood Cells |  | 
 10401-8 |  | Immune serum globulin given [Type] |  | 
 10402-6 |  | Immune serum globulin given [Volume] |  | 
 10403-4 |  | Inject immune serum globulin [Volume] |  | 
 10404-2 |  | Inject Rh immune globulin [Volume] |  | 
 10405-9 |  | Inject varicella zoster virus immune globulin [Volume] |  | 
 10406-7 |  | little i Ag [Presence] on Red Blood Cells from Blood product unit |  | 
 10407-5 |  | little i Ag [Presence] on Red Blood Cells from Donor |  | 
 10408-3 |  | little i Ag [Presence] on Red Blood Cells |  | 
 10409-1 |  | Pentaspan given [Volume] |  | 
 1041-3 |  | G Ag [Presence] on Red Blood Cells |  | 
 10410-9 |  | Plasma given [Type] |  | 
 10411-7 |  | Plasma given [Volume] |  | 
 10412-5 |  | Platelets given [Type] |  | 
 10413-3 |  | Rh immune globulin given [Volume] |  | 
 10414-1 |  | Transfuse albumin [Volume] |  | 
 10415-8 |  | Transfuse blood exchange transfusion [Volume] |  | 
 10416-6 |  | Transfuse blood product other [Volume] |  | 
 10417-4 |  | Transfuse cryoprecipitate [Volume] |  | 
 10418-2 |  | Transfuse factor IX [Volume] |  | 
 10419-0 |  | Transfuse factor VIII [Volume] |  | 
 1042-1 |  | H Ab [Presence] in Serum or Plasma from Blood product unit |  | 
 10420-8 |  | Transfuse immune serum globulin [Volume] |  | 
 10421-6 |  | Transfuse Pentaspan [Volume] |  | 
 10422-4 |  | Transfuse plasma [Volume] |  | 
 10423-2 |  | Transfuse platelets [Volume] |  | 
 10424-0 |  | Transfuse erythrocytes [Volume] |  | 
 10425-7 |  | Transfuse Rh immune globulin [Volume] |  | 
 10426-5 |  | Transfuse whole blood [Volume] |  | 
 10427-3 |  | Transfuse whole blood autologous [Volume] |  | 
 10428-1 |  | Varicella zoster virus immune globulin given [Volume] |  | 
 10429-9 |  | AE 1 Ag [Presence] in Tissue by Immune stain |  | 
 1043-9 |  | H Ab [Presence] in Serum or Plasma from Donor |  | 
 10430-7 |  | AE 3 Ag [Presence] in Tissue by Immune stain |  | 
 10431-5 |  | B-cell Ag [Presence] in Tissue by Immune stain |  | 
 10432-3 |  | CD30 Ag [Presence] in Tissue by Immune stain |  | 
 10433-1 |  | BR-2 Ag [Presence] in Tissue by Immune stain |  | 
 10434-9 |  | Complement C3 Ag [Presence] in Tissue by Immune stain |  | 
 10435-6 |  | C5B-9 Ag [Presence] in Tissue by Immune stain |  | 
 10436-4 |  | CD15 Ag [Presence] in Tissue by Immune stain |  | 
 10437-2 |  | CD16 Ag [Presence] in Tissue by Immune stain |  | 
 10438-0 |  | CD20 Ag [Presence] in Tissue by Immune stain |  | 
 10439-8 |  | CD3 Ag [Presence] in Tissue by Immune stain |  | 
 1044-7 |  | H Ab [Presence] in Serum |  | 
 10440-6 |  | Deprecated CD30 Ag [Presence] in Tissue by Immune stain |  | 
 10441-4 |  | CD34 Ag [Presence] in Tissue by Immune stain |  | 
 10442-2 |  | CD56 Ag [Presence] in Tissue by Immune stain |  | 
 10443-0 |  | CD43 T-cell monocyte+myeloid cell Ag [Presence] in Tissue by Immune stain |  | 
 10444-8 |  | CD57 Ag [Presence] in Tissue by Immune stain |  | 
 10445-5 |  | CD11c Ag [Presence] in Tissue by Immune stain |  | 
 10446-3 |  | Leukocyte common Ag [Presence] in Tissue by Immune stain |  | 
 10447-1 |  | M-5 Ag [Presence] in Tissue by Immune stain |  | 
 10448-9 |  | T-cell Ag [Presence] in Tissue by Immune stain |  | 
 10449-7 |  | Glucose [Mass/volume] in Serum or Plasma --1 hour post meal |  | 
 1045-4 |  | Deprecated H NOS Ab [Presence] in Serum or Plasma from Blood product unit |  | 
 10450-5 |  | Glucose [Mass/volume] in Serum or Plasma --10 hours fasting |  | 
 10451-3 |  | Proinsulin [Moles/volume] in Serum or Plasma --12 hours fasting |  | 
 10452-1 |  | Xylose [Mass/volume] in Serum or Plasma --1 hour post 25 g xylose PO |  | 
 10453-9 |  | Xylose [Mass/volume] in Serum or Plasma --1 hour post dose xylose PO |  | 
 10454-7 |  | Xylose [Mass/volume] in Serum or Plasma --2 hours post 25 g xylose PO |  | 
 10455-4 |  | Xylose [Mass/volume] in Serum or Plasma --30 minutes post 25 g xylose PO |  | 
 10456-2 |  | Xylose [Mass/volume] in Serum or Plasma --6 hours fasting |  | 
 10457-0 |  | Actin Ag [Presence] in Tissue by Immune stain |  | 
 10458-8 |  | Alkaline phosphatase.placental Ag [Presence] in Tissue by Immune stain |  | 
 10459-6 |  | Alpha-1-Fetoprotein Ag [Presence] in Tissue by Immune stain |  | 
 1046-2 |  | Deprecated H NOS Ab [Presence] in Serum or Plasma from Donor |  | 
 10460-4 |  | Lactalbumin alpha Ag [Presence] in Tissue by Immune stain |  | 
 10461-2 |  | Alpha-1-Antichymotrypsin Ag [Presence] in Tissue by Immune stain |  | 
 10462-0 |  | Alpha 1 antitrypsin Ag [Presence] in Tissue by Immune stain |  | 
 10463-8 |  | Amyloid A component Ag [Presence] in Tissue by Immune stain |  | 
 10464-6 |  | Amyloid P component Ag [Presence] in Tissue by Immune stain |  | 
 10465-3 |  | Amyloid.prealbumin Ag [Presence] in Tissue by Immune stain |  | 
 10466-1 |  | Anion gap 3 in Serum or Plasma |  | 
 10467-9 |  | Beta-2-Microglobulin amyloid Ag [Presence] in Tissue by Immune stain |  | 
 10468-7 |  | Calcitonin Ag [Presence] in Tissue by Immune stain |  | 
 10469-5 |  | Carcinoembryonic Ag [Presence] in Tissue by Immune stain |  | 
 1047-0 |  | Deprecated H NOS Ab [Presence] in Serum or Plasma |  | 
 10470-3 |  | Choriogonadotropin Ag [Presence] in Tissue by Immune stain |  | 
 10471-1 |  | Chromogranin A Ag [Presence] in Tissue by Immune stain |  | 
 10472-9 |  | Chromogranin Ag [Presence] in Tissue by Immune stain |  | 
 10473-7 |  | Chymotrypsin Ag [Presence] in Tissue by Immune stain |  | 
 10474-5 |  | Collagen type 4 Ag [Presence] in Tissue by Immune stain |  | 
 10475-2 |  | Corticotropin Ag [Presence] in Tissue by Immune stain |  | 
 10476-0 |  | Desmin Ag [Presence] in Tissue by Immune stain |  | 
 10477-8 |  | Enolase.neuron specific Ag [Presence] in Tissue by Immune stain |  | 
 10478-6 |  | Eosinophil major basic protein Ag [Presence] in Tissue by Immune stain |  | 
 10479-4 |  | CD227 Ag [Presence] in Tissue by Immune stain |  | 
 1048-8 |  | Deprecated H NOS Ag [Presence] on Red Blood Cells from Blood product unit |  | 
 10480-2 |  | Estrogen+Progesterone receptor Ag [Presence] in Tissue by Immune stain |  | 
 10481-0 |  | Follitropin.alpha subunit Ag [Presence] in Tissue by Immune stain |  | 
 10482-8 |  | Follitropin.beta subunit Ag [Presence] in Tissue by Immune stain |  | 
 10483-6 |  | Gastrin Ag [Presence] in Tissue by Immune stain |  | 
 10484-4 |  | Glial fibrillary acidic protein Ag [Presence] in Tissue by Immune stain |  | 
 10485-1 |  | Glucagon Ag [Presence] in Tissue by Immune stain |  | 
 10486-9 |  | Hemoglobin Ag [Presence] in Tissue by Immune stain |  | 
 10487-7 |  | HMB-45 Ag [Presence] in Tissue by Immune stain |  | 
 10488-5 |  | IgA Ag [Presence] in Tissue by Immune stain |  | 
 10489-3 |  | IgA.heavy chain Ag [Presence] in Tissue by Immune stain |  | 
 1049-6 |  | Deprecated H NOS Ag [Presence] on Red Blood Cells from Donor |  | 
 10490-1 |  | IgE Ag [Presence] in Tissue by Immune stain |  | 
 10491-9 |  | IgG Ag [Presence] in Tissue by Immune stain |  | 
 10492-7 |  | IgG.heavy chain Ag [Presence] in Tissue by Immune stain |  | 
 10493-5 |  | IgM Ag [Presence] in Tissue by Immune stain |  | 
 10494-3 |  | IgM.heavy chain Ag [Presence] in Tissue by Immune stain |  | 
 10495-0 |  | Insulin Ag [Presence] in Tissue by Immune stain |  | 
 10496-8 |  | Kappa light chains Ag [Presence] in Tissue by Immune stain |  | 
 10497-6 |  | Immunoglobulin light chains.kappa amyloid Ag [Presence] in Tissue by Immune stain |  | 
 10498-4 |  | Keratin Ag [Presence] in Tissue by Immune stain |  | 
 10499-2 |  | Lambda light chains Ag [Presence] in Tissue by Immune stain |  | 
 105-7 |  | Ceforanide [Susceptibility] by Disk diffusion (KB) |  | 
 1050-4 |  | Deprecated H NOS Ag [Presence] on Red Blood Cells |  | 
 10500-7 |  | Immunoglobulin light chains.lambda amyloid Ag [Presence] in Tissue by Immune stain |  | 
 10501-5 |  | Lutropin [Units/volume] in Serum or Plasma |  | 
 10502-3 |  | Lutropin Ag [Presence] in Tissue by Immune stain |  | 
 10503-1 |  | Lysozyme Ag [Presence] in Tissue by Immune stain |  | 
 10504-9 |  | Myelin basic protein Ag [Presence] in Tissue by Immune stain |  | 
 10505-6 |  | Myoglobin Ag [Presence] in Tissue by Immune stain |  | 
 10506-4 |  | Peanut agglutinin Ag [Presence] in Tissue by Immune stain |  | 
 10507-2 |  | Prolactin Ag [Presence] in Tissue by Immune stain |  | 
 10508-0 |  | Prostate specific Ag [Presence] in Tissue by Immune stain |  | 
 10509-8 |  | Prostatic acid phosphatase Ag [Presence] in Tissue by Immune stain |  | 
 1051-2 |  | Hemolytic disease of newborn screen [Interpretation] in Blood |  | 
 10510-6 |  | S-100 Ag [Presence] in Tissue by Immune stain |  | 
 10511-4 |  | Serotonin Ag [Presence] in Tissue by Immune stain |  | 
 10512-2 |  | Somatostatin Ag [Presence] in Tissue by Immune stain |  | 
 10513-0 |  | Somatotropin Ag [Presence] in Tissue by Immune stain |  | 
 10514-8 |  | Synaptophysin Ag [Presence] in Tissue by Immune stain |  | 
 10515-5 |  | Thyroglobulin Ag [Presence] in Tissue by Immune stain |  | 
 10516-3 |  | Thyrotropin Ag [Presence] in Tissue by Immune stain |  | 
 10517-1 |  | Trypsin Ag [Presence] in Tissue by Immune stain |  | 
 10518-9 |  | Ulex europaeus I lectin Ag [Presence] in Tissue by Immune stain |  | 
 10519-7 |  | Vimentin Ag [Presence] in Tissue by Immune stain |  | 
 1052-0 |  | Deprecated I (intermediate) subtype [Presence] in Serum or Plasma from Blood product unit |  | 
 10520-5 |  | Coagulation factor VI Ag [Presence] in Tissue by Immune stain |  | 
 10521-3 |  | Coagulation factor VIII Ag [Presence] in Tissue by Immune stain |  | 
 10522-1 |  | Coagulation factor XIII Ag [Presence] in Tissue by Immune stain |  | 
 10523-9 |  | Fibrinogen Ag [Presence] in Tissue by Immune stain |  | 
 10524-7 |  | Microscopic observation [Identifier] in Cervix by Cyto stain |  | 
 10525-4 |  | Microscopic observation [Identifier] in Specimen by Cyto stain |  | 
 10526-2 |  | Microscopic observation [Identifier] in Sputum by Cyto stain |  | 
 10527-0 |  | Microscopic observation [Identifier] in Tissue by Cyto stain |  | 
 10528-8 |  | Acetophenazine [Mass/volume] in Serum or Plasma |  | 
 10529-6 |  | Amoxapine metabolite [Mass/volume] in Serum or Plasma |  | 
 1053-8 |  | Deprecated I (intermediate) subtype [Presence] in serum or plasma from donor |  | 
 10530-4 |  | Aprobarbital [Mass/volume] in Serum or Plasma |  | 
 10531-2 |  | Bretylium [Mass/volume] in Serum or Plasma |  | 
 10532-0 |  | Deprecated Desethylamiodarone [Mass/volume] in Serum or Plasma |  | 
 10533-8 |  | Propoxyphene+Acetaminophen [Mass/volume] in Serum or Plasma |  | 
 10534-6 |  | Diazoxide [Mass/volume] in Serum or Plasma |  | 
 10535-3 |  | Digoxin [Mass/volume] in Serum or Plasma |  | 
 10536-1 |  | Dipyridamole [Mass/volume] in Serum or Plasma |  | 
 10537-9 |  | Deprecated Doxepin+Nordoxepin [Mass/volume] in Serum or Plasma |  | 
 10538-7 |  | Deprecated Fluoxetine+Norfluoxetine [Mass/volume] in Serum or Plasma |  | 
 10539-5 |  | glipiZIDE [Mass/volume] in Serum or Plasma |  | 
 1054-6 |  | Deprecated I (intermediate) subtype [Presence] in srum |  | 
 10540-3 |  | glyBURIDE [Mass/volume] in Serum or Plasma |  | 
 10541-1 |  | Mepivacaine [Mass/volume] in Serum or Plasma |  | 
 10542-9 |  | Metharbital [Mass/volume] in Serum or Plasma |  | 
 10543-7 |  | Methsuximide+Normethsuximide [Mass/volume] in Serum or Plasma |  | 
 10544-5 |  | Normeperidine [Presence] in Serum or Plasma |  | 
 10545-2 |  | Normephenytoin [Mass/volume] in Serum or Plasma |  | 
 10546-0 |  | Normethsuximide [Mass/volume] in Serum or Plasma |  | 
 10547-8 |  | Primidone+PHENobarbital [Mass/volume] in Serum or Plasma |  | 
 10548-6 |  | Phenytoin Free/Phenytoin.total in Serum or Plasma |  | 
 10549-4 |  | Pirmenol [Mass/volume] in Serum or Plasma |  | 
 1055-3 |  | Deprecated I (intermediate) subtype [Presence] on Red Blood Cells from Blood product unit |  | 
 10550-2 |  | Deprecated Temazepam [Mass/volume] in Serum or Plasma |  | 
 10551-0 |  | Triamterene [Mass/volume] in Serum or Plasma |  | 
 10552-8 |  | Tricyclic antidepressants [Mass/volume] in Serum or Plasma |  | 
 10553-6 |  | Prostatic acid phosphatase [Enzymatic activity/volume] in Genital fluid |  | 
 10554-4 |  | Deprecated Prostatic acid phosphatase [Enzymatic activity/volume] in Seminal plasma |  | 
 10555-1 |  | Acrosin [Entitic Catalytic Activity] in Spermatozoa |  | 
 10556-9 |  | Deprecated Adenosine triphosphatase [Enzymatic activity/volume] in Seminal plasma |  | 
 10557-7 |  | Adenosine triphosphate [Moles/volume] in Semen |  | 
 10558-5 |  | Albumin [Moles/volume] in Semen |  | 
 10559-3 |  | Deprecated Calcium [Molecules/volume] in Semen |  | 
 1056-1 |  | Deprecated I (intermediate) subtype [Presence] on Red Blood Cells from donor |  | 
 10560-1 |  | Carcinoembryonic Ag [Units/volume] in Semen |  | 
 10561-9 |  | Carnitine [Moles/volume] in Semen |  | 
 10562-7 |  | Cells [#/volume] in Cervical mucus |  | 
 10563-5 |  | Cells other than spermatozoa [#/volume] in Semen |  | 
 10564-3 |  | Cervical mucus [Volume] |  | 
 10565-0 |  | Choriogonadotropin [Units/volume] in Semen |  | 
 10566-8 |  | Deprecated Choriogonadotropin [Molecules/volume] in Semen |  | 
 10567-6 |  | Citrate [Moles/volume] in Semen |  | 
 10568-4 |  | Clarity of Semen |  | 
 10569-2 |  | Color of Semen |  | 
 1057-9 |  | Deprecated I (intermediate) subtype [Presence] on Red Blood Cells |  | 
 10570-0 |  | Consistency of Cervical mucus |  | 
 10571-8 |  | Deprecated Consistency of Semen |  | 
 10572-6 |  | Deprecated Duration^post ejaculation |  | 
 10573-4 |  | Ferning [Type] in Cervical mucus |  | 
 10574-2 |  | Fructose [Moles/volume] in Semen |  | 
 10575-9 |  | Deprecated Gamma glutamyl transferase [Enzymatic activity/volume] in Semen |  | 
 10576-7 |  | Germ cells.immature [#/volume] in Semen |  | 
 10577-5 |  | Glucosidase [Enzymatic activity/volume] in Seminal plasma |  | 
 10578-3 |  | Glycerophosphocholine [Moles/volume] in Seminal plasma |  | 
 10579-1 |  | Leukocytes [#/volume] in Semen |  | 
 1058-7 |  | I Ab [Presence] in Serum or Plasma from Blood product unit |  | 
 10580-9 |  | Liquefaction [Time] in Semen |  | 
 10581-7 |  | Deprecated Number of entities [#] in Spermatozoa |  | 
 10582-5 |  | pH of Cervical mucus |  | 
 10583-3 |  | Prostaglandin F1 alpha [Moles/volume] in Semen |  | 
 10584-1 |  | Deprecated Protein [Mass/volume] in Semen |  | 
 10585-8 |  | Round cells [#/volume] in Semen |  | 
 10586-6 |  | Deprecated Volume of Semen |  | 
 10587-4 |  | Sexual abstinence duration |  | 
 10588-2 |  | Spermatogonia [#/volume] in Semen |  | 
 10589-0 |  | Spermatids [#/volume] in Semen by Streptoavidin-biotin method (SAB) |  | 
 1059-5 |  | I Ab [Presence] in Serum or Plasma from Donor |  | 
 10590-8 |  | Spermatids [#/volume] in Semen by Sertoli cell barrier method (SCB) |  | 
 10591-6 |  | Primary Spermatocytes [#/volume] in Semen |  | 
 10592-4 |  | Secondary Spermatocytes [#/volume] in Semen |  | 
 10593-2 |  | Spermatozoa Pyriform Head/100 spermatozoa in Semen |  | 
 10594-0 |  | Spermatozoa Tapering Head/100 spermatozoa in Semen |  | 
 10595-7 |  | Deprecated Spermatozoa [#/volume] in Semen |  | 
 10596-5 |  | Deprecated Spermatozoa Ab in cervical mucosa |  | 
 10597-3 |  | Deprecated Spermatozoa Ab in semen |  | 
 10598-1 |  | Deprecated Spermatozoa Ab in serum |  | 
 10599-9 |  | Spermatozoa penetration [Presence] in Seminal fluid and Cervical mucosa by Kremer test |  | 
 106-5 |  | Ceforanide [Susceptibility] by Serum bactericidal titer |  | 
 1060-3 |  | I Ab [Presence] in Serum or Plasma |  | 
 10600-5 |  | Spermatozoa penetration [Presence] in Seminal fluid and Cervical mucosa |  | 
 10601-3 |  | Spermatozoa penetration [Presence] in Seminal fluid and Cervical mucosa --post coitus |  | 
 10602-1 |  | Spermatozoa Abnormal Head/100 spermatozoa in Semen |  | 
 10603-9 |  | Spermatozoa Abnormal Midpiece/100 spermatozoa in Semen |  | 
 10604-7 |  | Spermatozoa Abnormal Tail/100 spermatozoa in Semen |  | 
 10605-4 |  | Spermatozoa Agglutinated/100 spermatozoa in Semen |  | 
 10606-2 |  | Spermatozoa Amorphous Head/100 spermatozoa in Semen |  | 
 10607-0 |  | Spermatozoa Coiled Tail/100 spermatozoa in Semen |  | 
 10608-8 |  | Spermatozoa Cytoplasmic Droplet/100 spermatozoa in Semen |  | 
 10609-6 |  | Spermatozoa Duplicate Head/100 spermatozoa in Semen |  | 
 1061-1 |  | Deprecated I NOS Ab [Presence] in Serum or Plasma from Blood product unit |  | 
 10610-4 |  | Spermatozoa Duplicate Tail/100 spermatozoa in Semen |  | 
 10611-2 |  | Spermatozoa Immotile/100 spermatozoa in Semen |  | 
 10612-0 |  | Spermatozoa Large Oval Head/100 spermatozoa in Semen |  | 
 10613-8 |  | Spermatozoa Viable/100 spermatozoa in Semen |  | 
 10614-6 |  | Spermatozoa Motile w IgA/100 spermatozoa in Semen by Immunobead |  | 
 10615-3 |  | Spermatozoa Motile w IgA/100 spermatozoa in Semen by Mixed antiglobulin reaction |  | 
 10616-1 |  | Spermatozoa Motile w IgG/100 spermatozoa in Semen by Immunobead |  | 
 10617-9 |  | Spermatozoa Motile w IgG/100 spermatozoa in Semen by Mixed antiglobulin reaction |  | 
 10618-7 |  | Spermatozoa Motile w IgM/100 spermatozoa in Semen by Immunobead |  | 
 10619-5 |  | Spermatozoa Motile w IgM/100 spermatozoa in Semen by Mixed antiglobulin reaction |  | 
 1062-9 |  | Deprecated I NOS Ab [Presence] in Serum or Plasma from Donor |  | 
 10620-3 |  | Spermatozoa Nonprogressive/100 spermatozoa in Semen |  | 
 10621-1 |  | Spermatozoa Normal Head/100 spermatozoa in Semen |  | 
 10622-9 |  | Spermatozoa Normal/100 spermatozoa in Semen |  | 
 10623-7 |  | Spermatozoa Pin Head/100 spermatozoa in Semen |  | 
 10624-5 |  | Spermatozoa Rapid/100 spermatozoa in Semen |  | 
 10625-2 |  | Spermatozoa Round Head/100 spermatozoa in Semen |  | 
 10626-0 |  | Spermatozoa Slow/100 spermatozoa in Semen |  | 
 10627-8 |  | Spermatozoa Small Oval Head/100 spermatozoa in Semen |  | 
 10628-6 |  | Spermatozoa Tail Swelling/100 spermatozoa in Semen |  | 
 10629-4 |  | Spermatozoa Vacuolated Head/100 spermatozoa in Semen |  | 
 1063-7 |  | Deprecated I NOS Ab [Presence] in Serum or Plasma |  | 
 10630-2 |  | Spinnbarkeit [Length] in Cervical mucus |  | 
 10631-0 |  | Testosterone [Moles/volume] in Semen |  | 
 10632-8 |  | Time until next menstrual period |  | 
 10633-6 |  | Zinc [Moles/volume] in Semen |  | 
 10634-4 |  | Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma |  | 
 10635-1 |  | Acanthamoeba sp identified in Eye by Organism specific culture |  | 
 10636-9 |  | Acanthamoeba sp identified in Eye by Wet preparation |  | 
 10637-7 |  | Microscopic observation [Identifier] in Tissue by Night blue stain |  | 
 10638-5 |  | Thermophilic Actinomycetes colony count [#/volume] in Specimen by Organism specific culture |  | 
 10639-3 |  | Thermophilic Actinomycetes identified in Specimen by Organism specific culture |  | 
 1064-5 |  | Deprecated I NOS Ag [Presence] on Red Blood Cells from Blood product unit |  | 
 10640-1 |  | Deprecated Adenovirus 40+41 [Identifier] in Stool by Electron microscopy |  | 
 10641-9 |  | Amoeba identified in Aspirate by Immune stain |  | 
 10642-7 |  | Amoeba identified in Aspirate by Wet preparation |  | 
 10643-5 |  | Amoeba identified in Stool by Organism specific culture |  | 
 10644-3 |  | Arthropod identified in Specimen |  | 
 10645-0 |  | Aspergillus fumigatus Ag [Presence] in Tissue by Immunofluorescence |  | 
 10646-8 |  | Astrovirus [Identifier] in Stool by Electron microscopy |  | 
 10647-6 |  | Babesia sp identified in Blood by Thick film |  | 
 10648-4 |  | Babesia sp identified in Blood by Thin film |  | 
 10649-2 |  | Calicivirus [Identifier] in Stool by Electron microscopy |  | 
 1065-2 |  | Deprecated I NOS Ag [Presence] on Red Blood Cells from Donor |  | 
 10650-0 |  | Candida sp DNA [Presence] in Blood by Probe with amplification |  | 
 10651-8 |  | Chlamydophila pneumoniae Ag [Presence] in Sputum or Bronchial |  | 
 10652-6 |  | Chlamydophila pneumoniae DNA [Presence] in Sputum or Bronchial by Probe with amplification |  | 
 10653-4 |  | Clotrimazole [Susceptibility] by Minimum inhibitory concentration (MIC) |  | 
 10654-2 |  | Clotrimazole [Susceptibility] by Minimum lethal concentration (MLC) |  | 
 10655-9 |  | Coccidia identified in Duodenal fluid by Acid fast stain |  | 
 10656-7 |  | Coccidia identified in Stool by Acid fast stain |  | 
 10657-5 |  | Deprecated Cryptococcus neoformans Ag [Presence] in Tissue by Immunofluorescence |  | 
 10658-3 |  | Cyanobacterium identified in Water by Light microscopy |  | 
 10659-1 |  | Cyclospora sp identified in Stool by Acid fast stain |  | 
 1066-0 |  | Deprecated I NOS Ag [Presence] on Red Blood Cells |  | 
 10660-9 |  | Cytomegalovirus Ag [Presence] in Tissue by Immune stain |  | 
 10661-7 |  | Dinoflagellate identified in Water by Light microscopy |  | 
 10662-5 |  | Filaria identified in Blood by Concentration |  | 
 10663-3 |  | Filaria identified in Blood by Thick film |  | 
 10664-1 |  | Filaria identified in Blood by Thin film |  | 
 10665-8 |  | Fungus colony count [#/volume] in Specimen by Environmental culture |  | 
 10666-6 |  | Fungus identified in Tissue by Fontana-Masson stain |  | 
 10667-4 |  | Fungus identified in Specimen by Animal inoculation |  | 
 10668-2 |  | Fungus identified in Specimen by Environmental culture |  | 
 10669-0 |  | Fungus identified in Specimen by Sticky tape for environmental fungus |  | 
 1067-8 |  | Jk sup(a) Ab [Presence] in Serum or Plasma from Blood product unit |  | 
 10670-8 |  | Giardia lamblia [Presence] in Stool by Organism specific culture |  | 
 10671-6 |  | Helminth identified in Specimen |  | 
 10672-4 |  | Helminth+Arthropod identified in Specimen |  | 
 10673-2 |  | Hepatitis B virus core Ag [Presence] in Tissue by Immune stain |  | 
 10674-0 |  | Hepatitis B virus surface Ag [Presence] in Tissue by Immune stain |  | 
 10675-7 |  | Hepatitis B virus surface Ag [Presence] in Tissue by Orcein stain |  | 
 10676-5 |  | Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification |  | 
 10677-3 |  | Herpes simplex virus 1 Ag [Presence] in Tissue by Immune stain |  | 
 10678-1 |  | Herpes simplex virus 1+2 Ag [Presence] in Tissue by Immune stain |  | 
 10679-9 |  | Herpes simplex virus 2 Ag [Presence] in Tissue by Immune stain |  | 
 1068-6 |  | Jk sup(a) Ab [Presence] in Serum or Plasma from Donor |  | 
 10680-7 |  | Herpes simplex virus identified in Cerebral spinal fluid by Electron microscopy |  | 
 10681-5 |  | Herpes simplex virus identified in Tissue by Electron microscopy |  | 
 10682-3 |  | Deprecated HIV 1 RNA [Units/volume] in Serum or Plasma by Probe with amplification |  | 
 10683-1 |  | Hydatid cyst identified in Aspirate by Immune stain |  | 
 10684-9 |  | Hydatid cyst identified in Liver by Wet preparation |  | 
 10685-6 |  | Hydatid cyst identified in Lung tissue by Wet preparation |  | 
 10686-4 |  | Leishmania sp identified in Tissue by Giemsa stain |  | 
 10687-2 |  | Leishmania sp identified in Tissue by Organism specific culture |  | 
 10688-0 |  | Microscopic observation [Identifier] in Hair by KOH preparation |  | 
 10689-8 |  | Microscopic observation [Identifier] in Nail by KOH preparation |  | 
 1069-4 |  | Jk sup(a) Ab [Presence] in Serum or Plasma |  | 
 10690-6 |  | Microsporidia identified in Duodenal fluid by Trichrome stain modified |  | 
 10691-4 |  | Mushroom.toxic identified by Inspection |  | 
 10692-2 |  | Mushroom.toxic identified in Food by Light microscopy |  | 
 10693-0 |  | Mushroom.toxic identified in Vomitus by Light microscopy |  | 
 10694-8 |  | Naegleria sp identified in Tissue by Organism specific culture |  | 
 10695-5 |  | Naegleria sp identified in Tissue by Wet preparation |  | 
 10696-3 |  | Norovirus [Identifier] in Stool by Electron microscopy |  | 
 10697-1 |  | Nystatin [Susceptibility] by Minimum inhibitory concentration (MIC) |  | 
 10698-9 |  | Nystatin [Susceptibility] by Minimum lethal concentration (MLC) |  | 
 10699-7 |  | Onchocerca sp identified in Tissue by Wet preparation |  | 
 107-3 |  | Cefotaxime [Susceptibility] by Minimum lethal concentration (MLC) |  | 
 1070-2 |  | Jk sup(a) Ag [Presence] on Red Blood Cells from Blood product unit |  | 
 10700-3 |  | Orthopoxvirus [Identifier] in Skin by Electron microscopy |  | 
 10701-1 |  | Ova and parasites identified in Stool by Concentration |  | 
 10702-9 |  | Ova and parasites identified in Stool by Immune stain |  | 
 10703-7 |  | Ova and parasites identified in Stool by Kinyoun iron hematoxylin stain |  | 
 10704-5 |  | Ova and parasites identified in Stool by Light microscopy |  | 
 10705-2 |  | Human papilloma virus Ag [Presence] in Tissue by Immune stain |  | 
 10706-0 |  | Picornavirus [Identifier] in Stool by Electron microscopy |  | 
 10707-8 |  | Toxic Plant identified in Plant specimen by Inspection |  | 
 10708-6 |  | Toxic Plant identified in Vomitus by Light microscopy |  | 
 10709-4 |  | Plasmodium falciparum Ag [Units/volume] in Blood by Immunofluorescence |  | 
 1071-0 |  | Jk sup(a) Ag [Presence] on Red Blood Cells from Donor |  | 
 10710-2 |  | Plasmodium sp identified in Blood by Thin film |  | 
 10711-0 |  | Plasmodium vivax Ag [Units/volume] in Blood by Immunofluorescence |  | 
 10712-8 |  | Pneumocystis sp identified in Lung tissue |  | 
 10713-6 |  | Prototheca identified in Specimen by Culture |  | 
 10714-4 |  | Deprecated Rotavirus [Identifier] in Stool by Electron microscopy |  | 
 10715-1 |  | Schistosoma sp identified in Urine sediment by Light microscopy |  | 
 10716-9 |  | Schistosoma sp identified in Specimen by Organism specific culture |  | 
 10717-7 |  | Streptococcus pneumoniae Ab [Units/volume] in Serum by Latex agglutination |  | 
 10718-5 |  | Strongyloides sp Ab [Units/volume] in Serum by Immunoassay |  | 
 10719-3 |  | Taenia solium adult Ab [Units/volume] in Serum by Immunoblot |  | 
 1072-8 |  | Jk sup(a) Ag [Presence] on Red Blood Cells |  | 
 10720-1 |  | Terbinafine [Susceptibility] by Minimum inhibitory concentration (MIC) |  | 
 10721-9 |  | Terbinafine [Susceptibility] by Minimum lethal concentration (MLC) |  | 
 10722-7 |  | Torovirus [Identifier] in Stool by Electron microscopy |  | 
 10723-5 |  | Toxoplasma gondii IgA Ab [Units/volume] in Serum by Immunoassay |  | 
 10724-3 |  | Toxoplasma gondii IgE Ab [Units/volume] in Serum by Immunoassay |  | 
 10725-0 |  | Toxoplasma gondii DNA [Units/volume] in Body fluid by Probe with amplification |  | 
 10726-8 |  | Toxoplasma gondii [Presence] in Tissue by Giemsa stain |  | 
 10727-6 |  | Toxoplasma gondii identified in Tissue |  | 
 10728-4 |  | Trichomonas sp identified in Genital specimen by Organism specific culture |  | 
 10729-2 |  | Trypanosoma sp identified in Blood by Light microscopy |  | 
 1073-6 |  | Jk sup(b) Ab [Presence] in Serum or Plasma from Blood product unit |  | 
 10730-0 |  | Trypanosoma sp identified in Blood by Organism specific culture |  | 
 10731-8 |  | Trypanosoma sp identified in Blood by Thick film |  | 
 10732-6 |  | Trypanosoma sp identified in Blood by Thin film |  | 
 10733-4 |  | Trypanosoma sp identified in Blood by Wet preparation |  | 
 10734-2 |  | Varicella zoster virus identified in Skin by Electron microscopy |  | 
 10735-9 |  | Viral sequencing [Identifier] in Serum by Sequencing |  | 
 10736-7 |  | Virus identified in Cerebral spinal fluid by Electron microscopy |  | 
 10737-5 |  | Virus identified in Stool by Electron microscopy |  | 
 10738-3 |  | Virus identified in Tissue by Electron microscopy |  | 
 10739-1 |  | Virus identified in Specimen by Electron microscopy |  | 
 1074-4 |  | Jk sup(b) Ab [Presence] in Serum or Plasma from Donor |  | 
 10740-9 |  | Aluminum.microscopic observation [Identifier] in Bone by Histomorphometry stain |  | 
 10741-7 |  | Amyloid.microscopic observation [Identifier] in Brain by Thioflavine-S stain |  | 
 10742-5 |  | Amyloid.microscopic observation [Identifier] in Tissue by Bennhold stain.Putchler modified |  | 
 10743-3 |  | Amyloid.microscopic observation [Identifier] in Tissue by Highman stain |  | 
 10744-1 |  | Amyloid.microscopic observation [Identifier] in Tissue by Vassar-culling stain |  | 
 10745-8 |  | Bile.microscopic observation [Identifier] in Tissue by Fouchet stain |  | 
 10746-6 |  | Calcium.microscopic observation [Identifier] in Tissue by Von Kossa stain |  | 
 10747-4 |  | Collagen fibers+Elastic fibers.microscopic observation [Identifier] in Tissue by Lawson-Van Gieson stain |  | 
 10748-2 |  | Collagen fibers+Elastic fibers.microscopic observation [Identifier] in Tissue by Verhoeff-Van Gieson stain |  | 
 10749-0 |  | Collagen fibers.microscopic observation [Identifier] in Tissue by Van Gieson stain |  | 
 1075-1 |  | Jk sup(b) Ab [Presence] in Serum or Plasma |  | 
 10750-8 |  | Connective tissue.microscopic observation [Identifier] in Tissue by Trichrome stain.Masson |  | 
 10751-6 |  | Copper.microscopic observation [Identifier] in Tissue by Rhodamine stain |  | 
 10752-4 |  | Fat.microscopic observation [Identifier] in Milk by Sudan IV stain |  | 
 10753-2 |  | Fat.microscopic observation [Identifier] in Stool by Sudan IV stain |  | 
 10754-0 |  | Fat.microscopic observation [Identifier] in Tissue by Sudan IV stain |  | 
 10755-7 |  | Fungus.microscopic observation [Identifier] in Tissue by Methenamine silver stain.Grocott |  | 
 10756-5 |  | Glial fibers.microscopic observation [Identifier] in Tissue by Holzer stain |  | 
 10757-3 |  | Hematologic+Nuclear elements.microscopic observation [Identifier] in Tissue by Giemsa stain.May-Grunwald |  | 
 10758-1 |  | Iron.microscopic observation [Identifier] in Bone by Histomorphometry stain |  | 
 10759-9 |  | Iron.microscopic observation [Identifier] in Sputum by Gomori stain |  | 
 1076-9 |  | Jk sup(b) Ag [Presence] on Red Blood Cells from Blood product unit |  | 
 10760-7 |  | Iron.microscopic observation [Identifier] in Tissue by Gomori stain |  | 
 10761-5 |  | Iron.microscopic observation [Identifier] in Tissue by Other stain |  | 
 10762-3 |  | Microscopic observation [Identifier] in Blood by Hemosiderin stain |  | 
 10763-1 |  | Microscopic observation [Identifier] in Body fluid by Sudan black stain |  | 
 10764-9 |  | Microscopic observation [Identifier] in Sputum by Silver stain |  | 
 10765-6 |  | Microscopic observation [Identifier] in Tissue by Acetate esterase stain |  | 
 10766-4 |  | Microscopic observation [Identifier] in Tissue by Alcian blue stain |  | 
 10767-2 |  | Microscopic observation [Identifier] in Tissue by Alcian blue stain.sulfated |  | 
 10768-0 |  | Microscopic observation [Identifier] in Tissue by Alcian blue stain.with periodic acid-Schiff |  | 
 10769-8 |  | Microscopic observation [Identifier] in Tissue by Alizarin red S stain |  | 
 1077-7 |  | Jk sup(b) Ag [Presence] on Red Blood Cells from Donor |  | 
 10770-6 |  | Microscopic observation [Identifier] in Tissue by Argentaffin stain |  | 
 10771-4 |  | Deprecated Microscopic observation [Identifier] in Tissue by Rhodamine-auramine fluorochrome stain |  | 
 10772-2 |  | Microscopic observation [Identifier] in Tissue by Azure-eosin stain |  | 
 10773-0 |  | Microscopic observation [Identifier] in Tissue by Basic fuchsin stain |  | 
 10774-8 |  | Microscopic observation [Identifier] in Tissue by Bielschowsky stain |  | 
 10775-5 |  | Microscopic observation [Identifier] in Tissue by Bleach stain |  | 
 10776-3 |  | Microscopic observation [Identifier] in Tissue by Bodian stain |  | 
 10777-1 |  | Microscopic observation [Identifier] in Tissue by Brown and Brenn stain |  | 
 10778-9 |  | Microscopic observation [Identifier] in Tissue by Butyrate esterase stain |  | 
 10779-7 |  | Microscopic observation [Identifier] in Tissue by Carmine stain.Best |  | 
 1078-5 |  | Jk sup(b) Ag [Presence] on Red Blood Cells |  | 
 10780-5 |  | Microscopic observation [Identifier] in Tissue by Chloracetate esterase stain |  | 
 10781-3 |  | Microscopic observation [Identifier] in Tissue by Churukian-Schenk stain |  | 
 10782-1 |  | Microscopic observation [Identifier] in Tissue by Congo red stain |  | 
 10783-9 |  | Microscopic observation [Identifier] in Tissue by Crystal violet stain |  | 
 10784-7 |  | Microscopic observation [Identifier] in Tissue by Esterase stain.non-specific |  | 
 10785-4 |  | Microscopic observation [Identifier] in Tissue by Fite-Faraco stain |  | 
 10786-2 |  | Deprecated Microscopic observation [Identifier] in Tissue by Giemsa stain.3 micron |  | 
 10787-0 |  | Microscopic observation [Identifier] in Tissue by Gridley stain |  | 
 10788-8 |  | Microscopic observation [Identifier] in Tissue by Hansel stain |  | 
 10789-6 |  | Microscopic observation [Identifier] in Tissue by Hematoxylin-eosin-Harris regressive stain |  | 
 1079-3 |  | Js sup(a) Ab [Presence] in Serum or Plasma from Blood product unit |  | 
 10790-4 |  | Microscopic observation [Identifier] in Tissue by Hematoxylin-eosin-Mayers progressive stain |  | 
 10791-2 |  | Microscopic observation [Identifier] in Tissue by Mallory-Heidenhain stain |  | 
 10792-0 |  | Microscopic observation [Identifier] in Tissue by Methenamine silver stain.Jones |  | 
 10793-8 |  | Microscopic observation [Identifier] in Tissue by Methyl green stain |  | 
 10794-6 |  | Microscopic observation [Identifier] in Tissue by Methyl green-pyronine Y stain |  | 
 10795-3 |  | Microscopic observation [Identifier] in Tissue by Methyl violet stain |  | 
 10796-1 |  | Microscopic observation [Identifier] in Tissue by Mucicarmine stain |  | 
 10797-9 |  | Microscopic observation [Identifier] in Tissue by Neutral red stain |  | 
 10798-7 |  | Microscopic observation [Identifier] in Tissue by Oil red O stain |  | 
 10799-5 |  | Microscopic observation [Identifier] in Tissue by Pentachrome stain.Movat |  | 
 108-1 |  | Cefotaxime [Susceptibility] by Minimum inhibitory concentration (MIC) |  | 
 1080-1 |  | Js sup(a) Ab [Presence] in Serum or Plasma from Donor |  | 
 10800-1 |  | Microscopic observation [Identifier] in Tissue by Periodic acid-Schiff stain with diatase digestion |  | 
 10801-9 |  | Microscopic observation [Identifier] in Tissue by Phosphotungstic acid Hematoxylin (PTAH) Stain |  | 
 10802-7 |  | Microscopic observation [Identifier] in Tissue by Prussian blue stain |  | 
 10803-5 |  | Microscopic observation [Identifier] in Tissue by Quinacrine fluorescent stain |  | 
 10804-3 |  | Microscopic observation [Identifier] in Tissue by Reticulin stain |  | 
 10805-0 |  | Microscopic observation [Identifier] in Tissue by Safranin stain |  | 
 10806-8 |  | Microscopic observation [Identifier] in Tissue by Schmorl stain |  | 
 10807-6 |  | Microscopic observation [Identifier] in Tissue by Sevier-Munger stain |  | 
 10808-4 |  | Microscopic observation [Identifier] in Tissue by Silver impregnation stain.Dieterle |  | 
 10809-2 |  | Microscopic observation [Identifier] in Tissue by Silver nitrate stain |  | 
 1081-9 |  | Js sup(a) Ab [Presence] in Serum or Plasma |  | 
 10810-0 |  | Microscopic observation [Identifier] in Tissue by Silver stain.Fontana-Masson |  | 
 10811-8 |  | Microscopic observation [Identifier] in Tissue by Silver stain.Grimelius |  | 
 10812-6 |  | Microscopic observation [Identifier] in Tissue by Steiner stain |  | 
 10813-4 |  | Microscopic observation [Identifier] in Tissue by Sudan black stain |  | 
 10814-2 |  | Microscopic observation [Identifier] in Tissue by Supravital stain |  | 
 10815-9 |  | Microscopic observation [Identifier] in Tissue by Tetrachrome stain |  | 
 10816-7 |  | Deprecated Microscopic observation [Identifier] in Tissue by Toluidine blue O stain |  | 
 10817-5 |  | Microscopic observation [Identifier] in Tissue by Trichrome stain.Gomori-Wheatley |  | 
 10818-3 |  | Microscopic observation [Identifier] in Tissue by Trichrome stain.Masson modified |  | 
 10819-1 |  | Microscopic observation [Identifier] in Tissue by Wade stain |  | 
 1082-7 |  | Js sup(a) Ag [Presence] on Red Blood Cells from Blood product unit |  | 
 10820-9 |  | Deprecated Microscopic observation [Identifier] in Tissue by Warthin-Starry stain |  | 
 10821-7 |  | Deprecated Microscopic observation [Identifier] in Tissue by Wright Giemsa stain |  | 
 10822-5 |  | Mucin.microscopic observation [Identifier] in Tissue by Mucicarmine stain.Mayer |  | 
 10823-3 |  | Mucopolysaccharides.microscopic observation [Identifier] in Tissue by Colloidal ferric oxide stain.Hale |  | 
 10824-1 |  | Myelin+Myelin breakdown products.microscopic observation [Identifier] in Tissue by Luxol fast blue/Periodic acid-Schiff stain |  | 
 10825-8 |  | Myelin+Nerve cells.microscopic observation [Identifier] in Tissue by Luxol fast blue/Cresyl violet stain |  | 
 10826-6 |  | Nissel.microscopic observation [Identifier] in Tissue by Cresyl echt violet stain |  | 
 10827-4 |  | Reticulum.microscopic observation [Identifier] in Tissue by Gomori stain |  | 
 10828-2 |  | Urate crystals.microscopic observation [type] in Tissue by De Galantha stain |  | 
 10829-0 |  | Silicon [Mass/volume] in Serum or Plasma |  |